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Abstract 
 Host cell attachment by pathogenic bacteria can play very different roles in the 
course of infection.  The pathogenic spirochetes Borrelia hermsii and Borrelia 
burgdorferi sensu lato which cause relapsing fever and Lyme disease, respectively, are 
transmitted by the bite of infected ticks.  After transmission, these spirochetes can cause 
systemic infection.  Relapsing fever spirochetes remain largely in the bloodstream 
causing febrile episodes, while Lyme disease will often colonize a variety of tissues, such 
as the heart, joint and nervous system, resulting in a chronic multisystemic disorder.  
Borrelia species have the ability to bind to various cell types, a process which plays a 
crucial role in pathogenesis and may influence spirochetal clearance from the 
bloodstream.  Colonization of multiple tissues and cell types is likely promoted by the 
ability to bind to components found in target tissues, and many B. burgdorferi adhesins 
have been shown to promote attachment to a wide variety of cells and extracellular 
matrix components.  Different Lyme disease strains have been shown to preferentially 
colonize certain tissues, although the basis of this tissue tropism is not well understood.  
In this study we found that among different Lyme disease strains, allelic variation of the 
adhesin DbpA contributes to variation in its in vitro binding activities raising the 
possibility that this variation contributes to tissue tropism in vivo.  In studying B. hermsii 
infection, we found evidence by both histological and fluorescence in situ hybridization 
(FISH) analysis of tissues that indicated that red blood cells were removed by tissue 
resident macrophages in infected mice.  Spirochetes in the spleen and liver were often 
visualized associated with RBCs, lending support to the hypothesis that direct interaction 
of B. hermsii spirochetes with RBCs leads to clearance of bacteria from the bloodstream.  
Our findings indicate that host cell attachment play a key role in the establishment of 
Lyme disease infection, and in contrast contributes to the clearance of relapsing fever 
infection. 
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Borrelia species and human disease 
 Borrelia species are helical shaped motile bacteria that belong to the family 
Spirochaetaceae.  Although Borreliae are structurally Gram negative with an inner and 
outer membrane and are classified as such, their outer membranes are rich in lipoproteins 
and lack lipopolysaccharide (35, 58).  Another unique feature of spirochetes is the 
periplasmic location of their flagella, also known as axial filaments, which confer a spiral 
shape and are required for their corkscrew-like motility (16).  Other human pathogens in 
the spirochete family include the agents of syphilis (Treponema pallidum) and 
leptospirosis (Leptospira interrogans).    
 Although nearly 300 Borrelia species have been identified 
(http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=138), only 
approximately 15 of these are known to be pathogenic in humans.  Pathogenic Borreliae, 
are associated with  two important worldwide diseases, Lyme disease and relapsing fever 
(16).  Lyme disease is caused by at least seven species of Borrelia, with the most 
common being Borrelia burgdorferi sensu lato, which includes Borrelia burgdorferi 
sensu stricto (herein referred to as B. burgdorferi), Borrelia garinii and Borrelia afzelii.  
In Europe and Asia, Lyme disease is caused by all three species, while in the United 
States only B. burgdorferi is the major agent of disease (117, 142, 150).  Louse-borne 
relapsing fever is caused by Borrelia recurrentis, and is the cause of epidemic outbreaks.  
Tick-borne relapsing fever, also called endemic relapsing fever, is caused by Borrelia 
hermsii, Borrelia turicatae, and Borrelia duttonii (50).  While not as common as Lyme 
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disease, relapsing fever is nonetheless an important disease model for antigenic variation 
and valuable for the study of the immune system (16, 145).  Although both Lyme disease 
and relapsing fever are widely studied, many facets of the pathogenesis of these diseases 
still elude researchers. 
 
Lyme disease and the biology of Borrelia burgdorferi 
 Lyme disease is a complex, multisystemic disease.  First recognized in 1976 in   
Lyme, Connecticut in a group of children thought to have juvenile rheumatoid arthritis, 
the cause of the disease was not identified until 1982 (29).  It is the most common 
arthropod borne disease in the United States with nearly 40,000 cases reported in 2009 
(http://www.cdc.gov/ncidod/dvbid/lyme/index.htm).  Lyme disease occurs in three 
stages: localized or early stage, disseminated stage, and persistent or chronic stage (for 
reviews on Lyme disease, see (101, 142)).  During the localized stage, seven to ten days 
after the tick bite, spirochetes colonize the skin and can spread causing the characteristic 
bull’s-eye rash, erythema migrans (EM).  Other early symptoms of Lyme disease include 
fever, malaise, and other flu-like symptoms.  During the disseminated stage, which 
occurs 3 weeks to one month later, spirochetes spread into the bloodstream and multiple 
second EM lesions can occur.  At this time spirochetes may affect the central nervous 
system causing complications such as meningitis.  The chronic stage of Lyme disease can 
occur months to years after the initial tick bite if left untreated.  Lyme disease spirochetes 
have been shown colonize multiple tissues including the heart, joints, spleen, bladder, and 
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the nervous system (101).  The ability of Lyme disease Borreliae to colonize multiple 
tissues in the mammalian host can lead to a variety of complications.  Carditis, cardiac 
arrhythmia, and AV block have all been noted in chronic Lyme patients.  Arthritis, and 
muscle inflammation can result from colonization in the musculoskeletal system.  
Splenomegaly and damage to the liver and heart can occur and are also commonly seen 
in the murine model of Lyme disease.  Bell’s palsy, neuroborreliosis, and even 
psychiatric symptoms have been noted in Lyme disease patients indicating that Lyme 
disease spirochetes are capable of colonizing multiple tissues in the nervous system as 
well (71).  Chronic Lyme disease complications greatly depend on the species with which 
one was infected.  Most notably, the chronic manifestations commonly seen in Europe 
differ greatly and from those in North America, and evidence suggests that these 
differences depend on the Borrelia species prevalent in these areas (82, 150).   
 Certain Borrelia species, such as B. afzelii, generally do not disseminate but 
instead cause a local skin infection known as acrodermatitis (acrodermatitis chronica 
atrophicans), seen in approximately 10% of cases in Europe (141, 146).  Other strains do 
have the ability to disseminate and tend to preferentially colonize certain tissues such as 
the joints and the nervous systems.  For example, B. garinii is associated with 
neurological complications such as facial nerve paralysis (Bell’s palsy) (96), while B. 
burgdorferi is associated with Lyme arthritis which is the most common chronic 
manifestation of Lyme disease in the U.S. (142), and as mentioned above, B. burgdorferi 
is the only Borrelia species that has been identified in clinical cases of Lyme disease in 
the United States (117).   
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 In order to cause disease, B. burgdorferi must adapt to two very different 
environments.  In an unfed Ixodes tick, B. burgdorferi colonizes the tick midgut, and after 
a bite by an infected tick spirochetes migrate from the midgut to the salivary glands.  Due 
to the relatively slow migration process, ticks must feed for 24-48 hours in order to 
transmit spirochetes.  Several studies have shown that as the tick begins its blood meal, 
spirochetes begin to alter their gene expression pattern as their migration progresses 
(135).  Certain genes, such as outer surface protein (Osp) A, which is required for B. 
burgdorferi to persist in the tick (168), are downregulated during transmission to the host 
(48).  OspC on the other hand, is upregulated during this time and is required for B. 
burgdorferi infectivity in the mammalian host (65).  In addition, Borrelia genes that are 
only expressed in the mammalian host such as OspE, OspF, DbpA and the Elp (OspE-
like) proteins have also been identified (66, 109, 127).    
Borrelia genetics and disease severity     
 Within a species there can be considerable variation in the ability to cause 
disseminated disease.  However, the genetic basis for the varying ability of these 
genospecies to cause disseminated disease and preferentially colonize certain tissues is 
still not known.  Several groups have undertaken the task of distinguishing groups of 
Borrelia burgdorferi sensu stricto based on genotype of the highly variable ospC allele 
(53, 136, 158), or by RFLP analysis of rRNA gene spacer types (RST) (91, 92, 155, 156).  
By comparing different isolates of B. burgdorferi from the skin, blood and CSF, it was 
shown that different strains of B. burgdorferi can be subdivided into 21 different groups 
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according to the sequence of their ospC alleles.  Based on ospC lineage, it was shown that 
certain strains were more invasive while others tended not disseminate and caused a 
localized skin infection only (53).   An analogous pattern could be found when different 
strains were grouped by RST, where certain genotypes occurred at a greater frequency in 
strains isolated from the blood of infected patients than those isolated from skin (91, 92).  
 Genetic studies of Borrelia species have greatly lagged behind those of other 
pathogenic organisms.  In vitro cultivation of this organism is difficult; with a doubling 
time of  > 8 hours and the requirement of a rich defined medium (14).  In addition, Lyme 
disease Borreliae can be sensitive to minor changes in medium formulations, requiring 
careful attention to preparation and batch-to-batch variation (154).  It was not until 1997 
that the genome sequence of one strain of Borrelia burgdorferi (strain B31) was 
completed (58).  The availability of this sequence revealed several important features of 
Borrelia species, including the small size and complexity of its genome (~1.5 Mb) and 
the presence of extrachomosomal linear and circular plasmids, which can vary in number 
between Lyme disease Borrelia species (34, 35).  The sporadic loss of plasmids during in 
vitro growth greatly complicates our ability to generate defined genetic lesions in this 
organism, thus hampering genetic analysis of virulence (10, 11, 80, 105, 120, 140).  In 
addition, there are at least two known endogenous plasmid encoded restriction-
modification systems which rapidly degrade exogenous DNA, further hampering genetic 
manipulation of Borrelia species (81).   
 Within the last ten years, however, several tools have been developed that greatly 
advanced the ability of researchers to perform genetic studies with B. burgdorferi. These 
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tools include the development of shuttle vectors (144), the development of methods for 
mutagenesis including transposon mutagenesis (143, 169) and  modification of the Cre-
lox recombination system for use in B. burgdorferi (19).  In addition, our lab has shown 
that in vitro CpG methylation protects DNA from degradation and greatly enhances the 
efficiency of Borrelia transformation (37).  Purser et al. showed linear plasmid (lp) 25 
harbors the gene pncA (BBE22), which encodes a nicotinamidase and is required for 
infectivity in mice.  By complementing a strain lacking lp25 with a shuttle vector 
containing BBE22, the authors were able to restore infectivity in the murine host to near 
wild-type levels (119).  Plasmid lp28-1 has also been shown to be required for infectivity 
in the mouse model (120),  as well as being associated with causing Lyme related arthritis 
(165).  Within these plasmids, several genes which are required for cell adhesion and 
infectivity such as dbpA and dbpB (encoded on lp54) (67, 159), ospC (encoded on cp26) 
(128), and vlsE (encoded on lp28-1) (172) have also been identified. 
Cell adhesion by Lyme disease spirochetes 
  Host cell attachment is thought to be a critical first step for many pathogens for 
the establishment of infection.  Cell adhesion by B. burgdorferi has been widely studied, 
and it has been shown that this spirochete is able to bind to multiple different cell types in 
vitro including epithelial, endothelial and glial cells, platelets and lymphocytes (45, 49, 
59, 60, 147, 148).  Lyme disease spirochetes can invade and colonize multiple tissues in 
the untreated host, and have been shown to bind to multiple different host cell and 
extracellular matrix components such as integrins (39), fibronectin (24, 64, 118), 
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proteoglycans (67, 78, 86),  laminin (25, 152), and collagen (171).  A notable feature of 
Lyme disease Borreliae is that these pathogens express multiple different adhesins, each 
of which bind to one or more of these molecules (Table 1-1).  In addition, many borrelial 
adhesins are also required for infectivity, indicating that host cell attachment is indeed 
crucial for Lyme disease pathogenesis. 
 
 Two of the most widely studied of the Borrelia adhesins are decorin binding 
proteins (dbp) A and B.  DbpA and B are highly related surface lipoproteins first 
identified by showing that radiolabeled B. burgdorferi bound to decorin (67).  These 
proteins are encoded on a single operon and each bind to decorin, a proteoglycan with a 
dermatan sulfate glycosaminoglycan (GAG) side chain that “decorates” collagen fibers in 
mammalian tissues (66, 67, 70).  To establish an infection, Lyme disease spirochetes 
must migrate from the tick midgut to the salivary glands, and from there encounter the 
skin of the mammalian host.  In order to cause disseminated infection spirochetes 
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colonize the skin, a tissue rich in collagen.  Although some Borrelia strains bind directly 
to collagen depleted of decorin in vitro (171), this study did not rule out a requirement for 
decorin in collagen binding in vivo.  Some studies have shown that DbpA and DbpB 
require both the protein core and the GAG side chain for full binding to decorin (26, 115) 
while other studies have shown that the GAG side chain alone is sufficient for binding 
(57).  
  Lyme disease spirochetes have been shown to recognize distinct classes of 
GAGs, and variations in GAG-binding specificity appear to lead to differences in the 
types of mammalian cells recognized (113).  For example, B. burgdorferi strain N40, 
which recognizes heparan sulfate and dermatan sulfate GAGs, binds efficiently to glial 
and endothelial cells in vitro, while B. afzelii strain VS461, which predominately 
recognizes dermatan sulfate, binds selectively to glial cells (113).  In addition to binding 
decorin, DbpA and B from B. burgdorferi strain N40 differ in their GAG and mammalian 
cell type binding specificity (57).  Besides DbpA and B, B. burgdorferi encodes other 
GAG binding proteins, such as Bgp and BBK32 (56, 111).  These findings, together with 
the fact that Lyme disease spirochetes encode multiple GAG binding adhesins, suggest an 
important role for GAG binding in Lyme disease pathogenesis, and that strain specific 
differences in GAG recognition by Lyme disease spirochetes might influence the 
specificity of host cell attachment and thus tissue colonization during infection. 
 Glycosaminoglycans are a family of carbohydrates that consist of linear repeating 
disaccharide (a hexose or hexuronic acid and a hexosamine) chains.  Composition of 
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GAGs can vary in a number of ways including the type sugar, glycosidic linkage, 
acetylation, and sulfation pattern.  In addition to differences in structure, GAGs can also 
be either soluble or membrane bound.  GAGs are found in a variety of mammalian tissues 
including the extracellular matrix, cartilage, and connective tissues.  For example, 
heparan sulfate is the most ubiquitous GAG with 50-90% of total endothelial 
proteoglycans consisting of this polysaccharide.  In contrast, dermatan sulfate is found 
mainly on cell surfaces and in the extracellular matrix and is the predominant GAG found 
in the skin, while chondroitin sulfates are the major GAG species found in the central 
nervous system (72, 90, 149).  A number of different biological processes involve GAGs, 
including cell adhesion, receptor engagement and signal transduction (54, 79, 87).  As 
mentioned above, Lyme disease spirochetes have been shown to colonize multiple 
different tissues in very diverse hosts which can vary in their quantity and composition of 
GAGs.  Due to the structural diversity of GAGs, and the ubiquitous nature of these 
carbohydrates, one can imagine that Lyme disease Borreliae have evolved different 
GAG-binding adhesins in order to facilitate movement from the bloodstream to multiple 
different tissues during infection.               
 DbpA and B play crucial roles in Lyme disease pathogenesis.  Decorin was 
initially implicated in Lyme disease pathogenesis in experimental infections with decorin 
knockout (Dcn-/-) mice (27).  This study showed that in low dose infection, Dcn-/- mice 
had a lower incidence of dissemination to the joint and heart, a reduced incidence and 
severity of arthritis compared to Dcn+/- and Dcn+/+ mice.  This study was the first to show 
that decorin binding may have a role in spirochete dissemination and colonization of 
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certain tissues, as well requiring an interaction with decorin to cause arthritis.  Shi et al. 
initially reported that DbpA and DbpB are not required for infectivity in the mouse model 
(138).  This study examined a single high dose (105) infection in immunocompetent mice 
and SCID mice.  While there was no difference in tissue colonization in SCID mice, there 
was a mild defect in colonization of the joint (11/16 culture positive) and a more severe 
defect in colonization of the heart (3/16 culture positive) in immunocompetent mice 
(138), in agreement with the study using Dcn-/- mice which showed the same colonization 
defect.  The defect in colonization in the joint and heart was attributed to a possible 
defect due to genetic manipulation of their mutant, although a complemented mutant was 
not generated and analyzed.  However, a later study more comprehensive study by Shi et 
al. showed that while inactivation of the dbpBA locus did not completely abolish 
infectivity, the DbpA and B proteins are required for full virulence in mice infected by 
needle inoculation (137).  By deleting the dbpBA operon from strain B31 and examining 
multiple infectious doses in the mouse model, Weening et al. showed that DbpA and B 
are required for initial colonization and persistence in the murine host. Additionally, this 
study showed that DbpA and B are required for dissemination to, and colonization of 
certain tissues (159).  Liang and colleagues showed that overproduction of DbpA in an 
ospC deficient mutant reduces the ID50 and protects the bacteria from immune clearance 
in the skin of SCID mice.  This study also revealed that overproducing DbpA impairs 
dissemination from the initial site of infection (166).  Blevins et al. reported that DbpA 
and B are required for virulence in mice via needle inoculation, but not via tick 
inoculation (21), consistent with the fact DbpA and B are not expressed by Borrelia in 
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the tick vector (36, 167).  These studies suggest that DbpA may have several different 
roles in experimental infection, including key roles in dissemination and tissue 
colonization in the mouse model.    
 DbpA is highly polymorphic among Lyme disease spirochete strains while DbpB 
is highly conserved  (123).  In addition, recombinant derivatives of DbpA allelic variants 
differ in decorin binding (115).  However, the role of allelic variation of DbpA has not 
previously been examined.  The apparent requirement for DbpA in experimental Lyme 
disease pathogenesis and the diversity of dbpA alleles in different Lyme disease 
Borreliae, lead us to examine whether DbpA from multiple species influences binding to 
specific cell and tissue types and what role this variation may play in pathogenicity of 
Lyme disease. 
 
Relapsing fever 
 Relapsing fever is a disease that has been recorded since ancient times and is  
caused by the bite of infected soft-bodied (Ornithodorus) ticks or by exposure to the body 
louse (Pediculus humanus) (50).  Mice and other small rodents are the natural reservoirs 
for relapsing fever spirochetes.  This group includes B. recurrentis- the cause of epidemic 
outbreaks; while B. hermsii, B. duttonii, and B. turicatae are present in endemic areas.  
The most prevalent strain in the United States is B. hermsii, although less than 500 cases 
have been reported since 1977 (50).  Relaspsing fever spirochetes persistently colonize 
the salivary glands of Ornithodorus ticks.  Thus, in contrast to Ixodes ticks which must 
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feed for 24-48 hours in order transmit Lyme disease, Ornithodorus ticks require only 15-
90 minutes to transmit relapsing fever (134).  After an incubation period of a few days to 
a few weeks, spirochetes spread from the site of infection to the blood and the infected 
host experiences recurring episodes of high fever lasting several days followed by an 
afebrile period.  Without treatment these episodes can last for several months, with up to 
thirteen relapses and the duration of the afebrile period increasing between each 
occurrence of fever (for a recent review, see (51)).  The relapse phenomenon has been 
widely studied, and is now known to be caused by a switch in the major surface antigen 
expressed by relapsing fever spirochetes while in the mammalian host. 
Antigenic variation 
 Studies have shown that the febrile period coincides with a peak in bacteremia 
(~109/ml) in the blood (29), while the afebrile period is due to an expansion of B1b 
lymphocytes and anti-Borrelia (IgM) antibodies in the blood (2).  In order to evade the 
immune system, relapsing fever Borrelia species undergo switching of their surface 
antigens, called Vsp’s (variable small proteins) and Vlp’s (variable large proteins) (I will 
collectively refer to these proteins by their former name, Vmp’s- variable major proteins), 
each a unique serotype (74).   It was recognized early in the twentieth century that 
relapsing fever Borreliae undergo antigenic variation, although the idea that relapses 
were due to the outgrowth of antigenically distinct populations of Borrelia was not 
widely accepted at the time (133).  This phenomenon was nonetheless recognized as an 
important tool for studying the immune system (145).  In 1967, Coffey and Eveland 
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developed a method to identify specific populations of spirochetes obtained in a rat 
model of relapsing fever, and showed that spirochetes obtained from relapses were in fact 
of distinct serotypes.  In addition, the authors also found evidence that the serotype 
switching occurred in a predictable sequence (41, 42).  In a later study, Stoenner et al. 
provided evidence that as many as 25 unique serotypes can be generated from a single 
serotype, indicating that antigenic variation of relapsing fever spirochetes was far more 
complex than originally thought (145).  In addition, Stoenner showed that it was possible 
to recover the original serotype by infecting a naïve mouse with spirochetes recovered 
from a relapse population.  These findings were important because the data indicated that 
serotypes were not lost, and that antigenic variation is reversible (145).         
 The Vmp genes are encoded on linear plasmids, and while in the tick vector B. 
hermsii expresses Vsp33 (sometimes called Vtp33) (134).  Once a mammalian host is 
infected, a different Vmp is expressed.  Various studies revealed that the mechanism of 
antigenic variation involves gene conversion between a silent Vmp on an archive plasmid 
and the current Vmp on the expression plasmid (15).  For example, if Vsp21 is currently 
expressed and then replaced by Vsp7 at the expression locus, the new predominant 
serotype will be Vsp7.  Since there is very little cross-reactivity between the different 
serotypes, antibodies developed against the formerly expressed Vmp are ineffective 
against the newly expressed antigen thus allowing outgrowth of spirochetes during the 
relapse (9, 145).  Although the host immune response and mechanism of immune evasion 
by B. hermsii and other species of relapsing fever spirochetes is well studied, little is 
known about how this pathogen is cleared from the infected host.      
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Host cell binding by relapsing fever Borrelia species 
 Approximately 25 cases of relapsing fever are reported per year in the United 
States, although cases may be under reported since symptoms mimic other illnesses 
(http://www.cdc.gov/ncidod/dvbid/relapsingfever/index.htm).  Due the lack of mortality 
in cases of relapsing fever and the rare occurrence of the disease, very little is known 
about its pathogenesis.  In addition to episodes of high fever due to bacteremia, hallmark 
clinical features of relapsing fever include anemia and thrombocytopenia.  It is currently 
unknown how B. hermsii causes these hematological changes.  Various Lyme disease 
spirochetes have been show to bind integrin IIb, although this capability appears to be 
limited to infectious strains (38, 40).  Likewise, Borrelia hermsii also bind to platelets.  
This interaction results in platelet and IIb activation, which in turn enhances binding 
by spirochetes (5, 39).  Although B. hermsii activates platelets, an additional study 
showed that spirochete-bound platelets in the bloodstream are in the resting state.  This 
study also showed that platelet binding by B. hermsii can also occur independent of IIb 
and that this integrin is not involved in the induction of thrombocytopenia (6).    In 
relapsing fever patients, it is currently not known what becomes of activated platelets 
once they are bound by spirochetes, or how this interaction may contribute to 
thrombocytopenia.   
 In blood smears of infected mice, B. hermsii can be seen by darkfield microscopy 
bound to red blood cells (RBCs) as well as to platelets (68).  Another relapsing fever 
spirochete, B. crocidurae, becomes coated with red blood cells while in the bloodstream, 
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a phenomenon known as erythrocyte rosetting (30).  As with platelet binding by relapsing 
fever spirochetes, it is also unknown whether spirochete binding to RBCs is indeed the 
cause of anemia seen in human patients as well as in experimental infection.  In our 
study, we initially set out to test whether genetic background of the infected host plays a 
role in the outcome of relapsing fever infection.  In addition to our findings regarding the 
influences of host genetics and immune response to B. hermsii infection, we found that B. 
hermsii appears to invade the heart, spleen and liver of infected mice, and associates with 
RBCs within these tissues.  These observations lead us to hypothesize that RBC binding 
by B. hermsii may be a mechanism that leads to clearance of bacteria from the 
bloodstream- a sharp contrast to B. burgdorferi which appears to use host cell binding to 
establish its infection.     
 
Summary 
 In this study, we used the murine models of relapsing fever and Lyme disease in 
order to study the role of host cell attachment in the pathogenesis of these two important 
human diseases.  In the relapsing fever model, we analyzed the role of genetic 
background of the host in resistance to this disease.  While studies have been previously 
conducted to identify mammalian genes which influence sensitivity to B. burgdorferi 
infection (124, 160), this study was the first of its kind to examine the role of genetic 
background of the host in the control of B. hermsii infection.  We found profound 
differences in the outcome of B. hermsii infection in mice which indicate that the innate 
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immune response to this infection is under genetic control.  It is currently unknown how 
B. hermsii infection causes anemia or thrombocytopenia.  We found that host cell 
attachment may play a role in the clearance of this pathogen via binding to RBCs, an 
interaction that has previously been implicated as having a role in this disease.  In the 
Lyme disease model, we examined how allelic variation of a specific adhesin, DbpA, 
influences host cell binding and whether or not the heterogeneity of this surface located 
protein may be responsible for the tissue tropism seen in different Lyme disease 
genospecies.  Lyme disease spirochetes can colonize multiple tissues in the mammalian 
host, and tissue colonization appears to be strain- and species-specific.  We used a non-
adherent B. burgdorferi strain to characterize the binding phenotypes of different dbpA 
alleles.  We found that allelic variation of DbpA leads to dramatic differences in the 
ability of this adhesin to promote bacterial attachment to GAGs and mammalian cells.  
Using these two murine infection models, we were able to show that host cell attachment 
can play very different roles in bacterial pathogenesis. 
 
 
 
CHAPTER II 
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Genetic control of the innate immune response to 
Borrelia hermsii influences the course of relapsing fever 
in inbred strains of mice 
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Abstract 
 Host susceptibility to infection is controlled in large measure by the genetic 
makeup of the host.  Spirochetes of the genus Borrelia include nearly 40 species of 
vector-borne spirochetes that are capable of infecting a wide range of mammalian hosts, 
causing Lyme disease and relapsing fever.  Relapsing fever is associated with high-level 
bacteremia, as well as hematologic manifestations such as thrombocytopenia (i.e. low 
platelet numbers) and anemia. To facilitate studies of genetic control of susceptibility to 
Borrelia hermsii infection we performed a systematic analysis of the course of infection 
using immunocompetent and immunocompromised inbred strains of mice. Our analysis 
revealed that sensitivity to B. hermsii infections is genetically controlled.  In addition, 
whereas the role of adaptive immunity to relapsing fever spirochetes is well documented, 
we found that innate immunity contributes significantly to reduction of bacterial burden. 
Similar to human infection, progression of the disease in mice was associated with 
thrombocytopenia and anemia. Histological and fluorescence in situ hybridization (FISH) 
analysis of infected tissues indicated that red blood cells were removed by tissue resident 
macrophages, a process that could lead to anemia.  Spirochetes in the spleen and liver 
were often visualized associated with RBCs, lending support to the hypothesis that direct 
interaction of B. hermsii spirochetes with RBCs leads to clearance of bacteria from the 
bloodstream by tissue phagocytes. 
 
 
  
20 
 
Introduction 
  
 The Borrelia genus is formed by a group of bacteria that are small flexible helical 
spirochetes.  Lyme disease spirochetes, B.burgdorferi sensu lato (114), cause the most 
common arthropod-borne illness in the U.S. and are responsible for more than 20,000 
reported cases per year (117).  Relapsing fever is another important worldwide infection 
that is caused by several species of the genus Borrelia and is typified by high levels of 
growth of spirochetes in the bloodstream.  Epidemic relapsing fever is caused by Borrelia 
recurrentis and transmitted by body lice (47).  Endemic relapsing fever is transmitted by 
ticks and caused by several species of Borrelia, such as B. hermsii, B. turicatae, and B. 
duttoni (52)).   
 B. hermsii is the most important relapsing fever spirochete in the United States 
and is acquired by the bite of an infected Ornithodorus hermsi tick (50).  The first 
manifestation of relapsing fever is associated with high-titer (106 to 108 spirochetes/ml) 
growth of the spirochete in blood.  This infection is typified by recurrent febrile episodes, 
each of which corresponds to high-level bacteremia caused by antigenically distinct 
populations of bacteria (reviewed in references (9, 12, 135).  Antigenic switching is a 
consequence of the sequential expression of genes for serotype-specific major surface 
antigens known collectively as variable major proteins (Vmps). The mechanism of 
antigenic variation involves a gene rearrangement to localize a new variant vmp gene at a 
unique expression site (17).  The spirochete encodes many silent vmp genes, and at least 
25 antigenically distinct serotypes of this bacterium can be generated from a single 
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bacterium (122, 145).  Thus, a cycle of bacteremia, clearance, and outgrowth of antigenic 
variants can occur several times, giving rise to a relapsing illness.  The high-titer growth 
of Borrelia in the bloodstream results in a wide range of symptoms that include fever, 
chills, and muscle and joint aches.  After 2 to 9 days, these symptoms disappear, 
corresponding to the first clearance of bacteria from the blood, but the recurring nature of 
the bacteremia results in the reappearance of symptoms for several weeks, if left 
untreated.  In addition, blood infection is associated with several striking hematological 
abnormalities.  For example, thrombocytopenia, i.e., a low platelet count, is the most 
frequent laboratory manifestation of B. hermsii infection in humans, and normocytic 
anemia and leukocytosis are also common (22).  Both of these manifestations might 
involve interactions between host cells and blood-borne bacteria, because B. hermsii has 
been demonstrated to bind to platelets and red blood cells (RBCs) (6, 68).  In particular, 
not only were episodes of thrombocytopenia temporally and quantitatively correlated 
with episodes of bacteremia, but platelet-bacterium complexes were detected in infected 
mice (4).   
 Rodents are both natural hosts for relapsing fever spirochetes and provide an 
experimental model in which to investigate the pathogenesis of human infection.  Murine 
infection recapitulates a number of pathophysiological aspects of the human disease, 
most notably the hallmark of recurrent episodes of severe (~107 to 108/ml) bacteremia.  In 
addition, hematological manifestations, such as leukocytosis, anemia, and 
thrombocytopenia that are commonly observed in human patients are associated with the 
episodes of recurrent spirochetemia in mice.  Thus, the groundbreaking discovery that 
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immune evasion by relapsing fever spirochetes was due to antigenic variation resulting 
from genomic rearrangements relied upon murine infection to generate antigenic variants 
(9, 145).  The murine model also provided a system in which to identify critical 
components of an adaptive immune response required for clearance of B. hermsii from 
the bloodstream.  MT-/- mice that lack B cells are completely susceptible to relapsing 
fever (46), and passive transfer experiments demonstrated that antibodies are essential 
effector molecules in protection from relapsing fever (7, 170).  Interestingly, the B cells 
confer protection independently from T-cell help (2, 13, 102).  T-cell-independent 
antibody responses occur with remarkable speed, consistent with the observation that 
each episode of spirochetemia lasts only two or three days.  Finally, immune 
reconstitution of recombination-activating gene (rag)-deficient mice revealed that a 
subclass of T-independent B cells termed B1b cells was capable of conferring long-term 
immunity to B. hermsii infection (3). 
 Whereas the role of an adaptive immune response in the clearance of relapsing 
fever spirochetes has been the focus of significant scientific investigation, very little is 
known about the role of innate immune mechanisms and spirochetemia.  Although mice 
deficient in adaptive immunity, such as rag and scid mutants, cannot resolve Borrelia 
infection completely, they possess some means of transiently controlling relapsing fever 
spirochetes.  Thus, while infection of rag2-/- mice with B. hermsii leads to a rapid 
increase in the number of blood-borne bacteria that peaks at day 3 postinfection, in the 
ensuing days, the level of bacteremia in these mice diminishes significantly, indicating 
that innate immunity contributes to effective control of this bacterial infection.  These 
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observations prompt the question of how mice manage to control bacteremia even in the 
absence of an adaptive response. 
 Inbred strains of mice have been used extensively in the analysis of genetic 
control of infectious diseases (28).  Several genes identified by genetic mapping have 
been shown to play an important role in the development and progression of human 
diseases.  One of the most prominent examples is Nramp1/SLC11A1, which encodes a 
divalent cation transporter (20).  Nramp1 was identified as a gene controlling 
susceptibility to a wide range of pathogens, such as Leishmania, Salmonella, and 
Mycobacterium bovis (153).  Inbred strains of mice were used extensively for studies of 
genetic control of differences in sensitivity to diseases induced by B. burgdorferi 
infection.  These studies identified several quantitative trait loci (QTL) that control B. 
burgdorferi-induced arthritis and levels of specific and total IgGs (124, 160).  Subsequent 
analysis of 10 different phenotypic readouts identified up to 14 QTL that control various 
aspects of B. burgdorferi infection (124).  To date, there are no studies of the contribution 
of genetic variation of the host to control of B. hermsii infection.  In order to develop an 
experimental system to study the role of innate immunity in the control of blood-borne 
bacteremia, we performed a survey of common inbred mouse strains.  We identified 
several significant differences in the course and outcome of B. hermsii infection in inbred 
strains of mice that indicate genetic control of both innate and adaptive response to this 
infection. 
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Experimental procedures 
 
Mice.  The mouse strains BALB/cByJ, C57BL/6ByJ, C3H/HeJ, DBA/1J, and SJL/J were 
purchased from Jackson Laboratories (Bar Harbor, ME).  Information regarding the 
differences in the genetic backgrounds of these mouse strains is available on the Jackson 
website (http://www.informatics.jax.org/strains_SNPs.shtml).  All wild-type mice were 
females between 4 and 6 weeks of age.  Female rag2-/- mice in the BALB/c, C57BL/6, 
and C3H/HeN backgrounds were purchased from Taconic Farms (Germantown, NY). 
rag2
-/- mice were also between 4 and 6 weeks of age.  Additional male and female rag2-/- 
mice for this study were bred in the animal facility at the University of Massachusetts 
Medical School.  Mice used in this study were housed in microisolator cages in the 
Department of Animal Medicine. 
 
B. hermsii infections and blood sampling.  To generate standardized stocks of highly 
infectious bacteria, B. hermsii bacteria were harvested from the blood of infected 
secretory IgM-deficient (sIgM-/-) mice, which suffer high-level (~108/ml) bacteremia, by 
cardiac puncture and frozen in 20% glycerol until needed.  Five rag2-/- mice of BALB/c, 
C57BL/6, or C3H/HeN background were infected intravenously with 105 Borrelia 
hermsii strain DAH bacteria (74) in 100 l of BSK-H medium (Sigma-Aldrich Co., St. 
Louis, MO).  Blood sampling was carried out as previously described (5).  Briefly, less 
than 1 mm of the tail was cut with surgical scissors, and 5 l of blood was taken with a 
micropipette and placed in 45 l of anticoagulant (100 mM citric acid, 100 mM sodium 
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citrate in phosphate buffered saline [PBS], pH 7.0).  Bacteremia was monitored at 24-h 
intervals for 5 days for wild-type mice and at 12- or 24-h intervals for 14 days for rag2-/- 
mice.  The levels of B. hermsii bacteria in these blood samples were evaluated by diluting 
10 l of the above-described blood sample into 40 l of phosphate buffered dextrose (2% 
dextrose in PBS, pH 7.0) for a final dilution of 1:50.  Five-microliter amounts of the 
diluted blood samples were examined under dark-field microscopy (400X magnification) 
to quantify the number of B. hermsii bacteria, as described previously (5).  The limit of 
detection of B. hermsii bacteria by this approach is 1 X 105 bacteria/ml. 
 
Flow cytometry.  One microliter of whole blood was diluted 1:10 in citrate 
anticoagulant.  Phycoerythrin (PE)-Cy5-conjugated anti-mouse TER-119 (eBioscience) 
was diluted 1:10, and PE-conjugated anti-mouse CD61 antibody (BD Pharmingen) was 
diluted 1:200 in phosphate-buffered dextrose to label red blood cells and platelets, 
respectively.  To measure the platelet and red blood cell counts by flow cytometry, 10 l 
of SPHERO rainbow fluorescent polystyrene beads (Spherotech, Inc., Libertyville, IL) 
was added as an internal standard, as described previously (4).  The numbers of red blood 
cells and platelets were measured by flow cytometry using a Becton-Dickinson 
FACSCalibur.  All flow cytometry experiments were performed within 2 days of 
collection of blood samples. 
 
Histology.  Tissues were harvested from infected mice at days 5 and 14 postinfection, 
fixed in 10% histological-grade buffered formalin, and then embedded in paraffin.  Five- 
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micrometer sections of spleen and liver were cut and then stained with hematoxylin and 
eosin (H&E). 
 
FISH.  For fluorescence in situ hybridization (FISH) analysis, tissues were harvested 
from infected mice at days 5 and 14 postinfection and fixed in 3.7% histological grade 
formaldehyde with 50% ethanol in phosphate-buffered saline.  Tissues were embedded in 
methacrylate and sectioned as described previously (100).  A Borrelia genus-specific 
oligonucleotide probe, reBorr0 (5’-GCATGCTTAAGACGCACTGCC-3’), was designed 
and 5’ end labeled with Cy3 (indocarbocyanine) (Biomers, Ulm, Germany).  To control 
for specificity of the probe, Borrelia garinii strain 1B29 (kindly provided by A. 
Schönberg, Federal Institute for Health Protection of Consumers and Veterinary 
Medicine, Berlin, Germany) and Treponema denticola (ATCC 35405) with two 
mismatches at the probe binding site were included as positive and negative controls, 
respectively, in each FISH experiment.  Sections (3 m) were hybridized as published 
previously (131), using a hybridization buffer containing 20% formamide.  After 
incubation at 50°C for 2 h, slides were rinsed with double-distilled water, air dried, and 
mounted with Vectashield mounting medium (Vector Laboratories, Burlingame, CA) 
containing the nonspecific nucleic acid stain DAPI (4’,6’-diamidino-2-phenylindole).  
For microscopy, an epifluorescence microscope (Axioplan2; Carl Zeiss, Jena, Germany) 
equipped with narrow-band filter sets (AHF; Analysentechnik, Tübingen, Germany) was 
used. 
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Statistical analysis.  Data were analyzed using GraphPad Prism.  Comparison of 
multiple groups was performed using one-way analysis of variance (ANOVA), and the 
significance of differences was evaluated with Bonferroni’s multiple comparison test.  
Statistical significance of difference between two groups was evaluated using two-tailed 
unpaired t tests.  In all tests, P values below 0.05 were considered statistically significant. 
In all graphs, error bars represent standard deviations. 
 
 
 
 
 
  
28 
 
Results 
 
Immunocompetent BALB/c mice are relatively resistant to B. hermsii infection.   
 In order to test whether a phenotypic difference in resistance to B. hermsii exists 
among inbred strains of mice, we infected intraperitoneally (i.p.) mice of five different 
strains, BALB/cByJ, C57BL/6ByJ, C3H/HeJ, DBA/1J, and SJL/J (Jackson Laboratory, 
Bar Harbor, ME), with 105 B. hermsii strain DAH bacteria.  These strains were chosen to 
match the progenitors of existing recombinant inbred mapping panels.  For this initial   
survey, female mice were infected in groups of five, and bacteremia was evaluated daily 
by dark-field microscopy of diluted blood samples as previously described (5).  
Following the initial experiments, we established that an intravenous (i.v.) route of 
infection provides a more reproducible course of infection than i.p. injection (data not 
shown).  Thus, all subsequent experiments used i.v. infection for delivery of spirochetes 
to the bloodstream.  Previous extensive study of infections in C57BL/6 mice indicated 
that peak bacteremia of B. hermsii strain DAH infection occurs on day 3 postinfection (3, 
6).  Thus, to discern potential phenotypic differences among different mouse strains, we 
chose to compare bacteremia at day 3 postinfection.  We found that BALB/cByJ was the 
most resistant strain, displaying a level of bacteremia 5-fold lower than in C57BL/6ByJ 
mice and 4-fold lower than in C3H/HeJ mice (Fig. 2-1).  DBA/1J and SJL/J mice had 
intermediate levels of bacteremia (data not shown).  Two additional surveys with strains 
BALB/cByJ, C57BL/6ByJ, and C3H/HeJ revealed these phenotypic differences to be 
reproducible and significant between BALB/cByJ and C57BL/6ByJ (P < 0.01) and  
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between BALB/cByJ and C3H/HeJ (P < 0.05) mice (Fig. 2-1, day 3). 
 
 
 
 
 
 
 
C57BL/6 rag2-/- mice are relatively resistant to B. hermsii infection.   
 Initial observations in rag1-/- mice indicated that bacteremia peaked at day 3 or 4 
postinfection, followed by a 10- to 20-fold decrease in bacterial load (2).  Thus, some 
degree of control of bacteremia was evident even in the absence of the adaptive immune 
system, suggesting a substantial contribution of innate immunity in this process.  To 
determine if differences in the response to B. hermsii infection observed with the 
immunocompetent wild-type mice described above might reflect genetic differences in 
the function(s) of the innate immune system, we analyzed the course and outcome of B. 
Figure 2-1.  Differences in control of B. hermsii infection among common inbred strains of 
mice.  Wild-type female BALB/cByJ, C57BL/6ByJ, and C3H/HeJ mice were infected i.v. in 
groups of five with 105 B. hermsii strain DAH bacteria.  Bacteremia was monitored daily by 
microscopic examination of blood smears.  The limit of detection of spirochetes by this approach 
is 1 X 105 bacteria/ml of blood.  Inset shows spirochete numbers in the bloodstreams of individual 
mice at day 3postinfection, along with means and standard deviations for the groups.  At this time 
point, there were significant differences in levels of bacteremia between BALB/cByJ and 
C57BL/6ByJ mice (P < 0.01) and between BALB/cByJ and C3H/HeJ mice (P < 0.05) as 
determined by one-way ANOVA with Bonferroni’s multiple comparison test. 
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hermsii infection in rag2-/- mice of different strain backgrounds.  Although rag2-/- mice 
suffer a persistent B. hermsii infection, they survive for approximately 12 to 21 days, 
allowing us to assess the role of the innate immune system in control of B. hermsii 
bacteremia.  For these experiments, we selected rag2-/- counterparts of the three strains 
that showed the greatest differences at day 3 postinfection when the infection was 
performed in wild-type mice.  BALB/c rag2-/-, C57BL/6 rag2-/-, and C3H/HeN rag2-/- 
mice were infected i.v. with 105 B. hermsii strain DAH bacteria and bled every 12 or 24 h 
for 14 days.  Bacteremia was monitored daily by dark-field microscopy of blood smears. 
 
 The three strains examined exhibited significant differences in the level of 
bacteremia, and these differences are described below.  Nevertheless, an overall triphasic 
Figure 2-2.  The efficiency of innate 
immune control of B. hermsii bacteremia 
varies with mouse strain.  Two 
independent surveys (A and B) reveal a 
genetically defined course of B. hermsii 
spirochetemia in rag2-/- mice.  Female mice 
between 4 and 6 weeks of age were infected 
i.v. in groups of five with 105 B. hermsii 
strain DAH bacteria.  Five microliters of 
blood per day was collected from each 
mouse for 14 days postinfection for 
microscopic examination of blood smears.  
Inset shows spirochete numbers in 
bloodstreams of individual mice at day 4 
postinfection, along with means and 
standard deviations for the groups.  At this 
time point, C3H/HeN rag2-/- mice 
demonstrated significantly (P < 0.001, one-
way ANOVA) higher levels of bacteremia 
than BALB/c rag2-/- or C57BL/6 rag2-/- 
mice. 
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pattern of infection was apparent for each of the three inbred strains (Fig. 2-2).  First, the 
mice suffered a single peak of bacteremia that was then partially controlled by day 6 
postinfection.  Second, this was followed by a period of four to six days in which the 
bacteremia was moderate and relatively consistent.  Finally, bacteremia increased, and in 
two of the three strains, this increase was dramatic, leading to morbidity and mortality. 
 While the overall pattern of bacteremia showed some similarities among the three 
rag2
-/- mouse strains, we were able to identify three periods over the course of the 14-day 
infection during which there were significant differences in bacteremia between the 
strains tested.  First, at days 3.5 to 4 postinfection, we found that BALB/c rag2-/- mice 
suffered approximately 2.5-fold lower bacteremia than C3H/HeN rag2-/- mice, consistent 
with the relative susceptibilities of their wild-type counterparts, BALB/cByJ and 
C3H/HeJ mice, respectively.  Interestingly, C57BL/6 rag2-/- mice were relatively 
resistant, suffering less than half the level of bacteremia (P < 0.01) seen in C3H/HeN 
rag2
-/- mice (Fig. 2-2A, see inset), a finding in contrast to the results for wild-type 
C57BL/6 mice, which were relatively susceptible to B. hermsii infection at the first peak 
of bacteremia (Fig. 2-1).  In addition, while none of the rag2-/- mice cleared B. hermsii 
infection, after the first peak of bacteremia, C57BL/6 rag2-/- mice were able to control 
bacteremia better and survived longer than either C3H/HeN rag2-/- or BALB/c rag2-/- 
mice.   
 Second, at approximately day 7 postinfection, BALB/c rag2-/- mice suffered an 
additional peak of bacteremia that was not observed with the other strains (Fig. 2-2A). 
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Thus, at this time point, BALB/c rag2-/- mice had 6-fold (P < 0.001) and 10-fold (P < 
0.001) higher numbers of blood-borne bacteria than C3H/HeN rag2-/- and C57BL/6  
rag2
-/-  mice, respectively.  By day 9 postinfection, BALB/c rag2-/- mice were able to 
establish partial (albeit temporary) control of bacteremia.  Finally, between days 12 and 
14 post-infection, BALB/c rag2-/- mice displayed approximately 10-fold greater 
bacteremia than C57BL/6 rag2-/- mice (P < 0.05 at day 12 for all experiments).  During 
this period of time, C3H/HeN rag2-/- mice had intermediate numbers of bacteria in the 
bloodstream.  The increase in bacteremia in BALB/c rag2-/- and C3H/HeN rag2-/- mice 
corresponded to signs of clinical illness, such as listlessness and ruffled fur, prompting 
euthanasia of many of the mice (data not shown).  Thus, although it has been established 
that an antibody response is critical for clearing B. hermsii infection in wild-type mice, 
the variation in response to infection by different strains of rag2-/- mice indicates that 
innate components of the immune system also contribute to the clearance of B. hermsii 
from the bloodstream. 
 
B. hermsii induced thrombocytopenia and anemia.  
 Associated with the episodes of spirochetemia in mice are anemia and 
thrombocytopenia, which are also commonly observed in human patients (6, 62).  Thus, 
in addition to monitoring bacteremia, in the second strain survey of rag2-/- strains (Fig. 2- 
2B), we also followed RBC and platelet counts by flow cytometry (see Materials and  
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Methods).  Consistent with earlier analysis of B. hermsii infection in 
immunocompromised mice (6), all mice became thrombocytopenic.  The kinetics of 
thrombocytopenia were similar across all mouse strains examined (Fig. 2-3A).  Over the 
first three days, there was a rapid decrease in the number of platelets, with platelet counts 
reaching 10 to 20% of normal levels by day 3 postinfection, the time point of peak 
bacteremia.  The platelet counts recovered very slightly over the next few days, but the 
mice remained severely thrombocytopenic.  At day 12 postinfection, the average platelet 
count dropped even further.  The platelet count profiles among all three strains of mice 
were highly similar, although the counts of BALB/c rag2-/- mice recovered slightly better 
Figure 2-3.  
Thrombocytopenia and 
anemia in rag2-/- mice.  Blood 
sampled from bacteremic rag2-/- 
mice was used for flow 
cytometry based measurement 
of platelets (A) and RBCs (B).  
Rapid initial reduction in the 
numbers of RBCs and platelets 
was followed by a recovery 
period in all 3 strains of mice 
examined.  The minimum in the 
platelet numbers corresponded 
to the peak bacteremia at day 4.  
The minimum in the number of 
RBCs corresponded to the 
minimum bacterial loads 
following the initial peak of 
bacteremia. 
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than those of the other strains (P < 0.05 for day 5).  We conclude that the genetic 
background of these mice has little influence on the development and course of 
thrombocytopenia during relapsing fever infection. 
 Measurement of RBC counts indicated that infection affects the numbers of 
RBCs, but not in a fashion synchronous with changes in platelet numbers.  We discerned 
three phases of anemia in immunocompromised mice.  In the first phase, RBC counts in 
infected mice began to decline rapidly early in infection, although less precipitously than 
platelet counts (Fig. 2-3B).  Unlike the platelet numbers, for which the period of rapid 
decline was limited to the first three days of infection, RBC numbers continued to decline 
until day 6.  At this time point, all three strains of mice had only 30% to 45% of their 
normal number of RBCs.  Interestingly, this time point corresponded to the point at 
which bacteremia was at a minimum following the initial peak of bacteremia at day 3 to 4 
(Fig. 2-2).  In the second phase, after day 6, the RBC count partially recovered and held 
steady for approximately four to six days, until about day 11 postinfection.  Finally, the 
RBC count diminished in all three mouse strains through day 14, at which point the 
experiment was terminated due to frank illness of the animals.  This third phase 
corresponded to an increase in bacteremia in all three strains. However, the degree of 
anemia did not directly correlate with the degree of bacteremia.  For example, at day 12 
postinfection, while both C3H/HeN rag2-/- and BALB/c rag2-/- mice had very high levels 
of bacteremia (>2 X 108) (Fig. 2-2), C3H/HeN rag2-/- mice had approximately 12-fold 
lower red blood cell counts than BALB/c rag2-/- mice (P < 0.001) (Fig. 2-3B).  In 
addition, whereas the bacterial load in C57BL/6 rag2-/- mice at days 12 to 14 was 
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considerably lower than that in C3H/HeN rag2-/- and BALB/c rag2-/- mice, the C57BL/6 
mice displayed a level of anemia intermediate between the levels in the other two strains. 
Therefore, our results indicate that changes in the number of RBCs following B. hermsii 
infection (Fig. 2-3B) do not simply reflect bacterial burdens and thus appear to be under 
independent genetic control. 
 
Sex-specific differences in innate control of B. hermsii infection.    
 The gender of the host often influences the course and outcome of infection.  To 
determine if innate immune control of B. hermsii infection has a sex-specific component, 
we compared the courses of infection in male and female littermates.  We infected five 
male and five female littermates of the BALB/c rag2-/- and C57BL/6 rag2-/- strains with 
105 B. hermsii strain DAH bacteria via tail vein injection.  In both strains examined, we 
found that at the early time point (days 3 to 4), male littermates suffered 2- to 4-fold 
higher levels of bacteremia than their female counterparts (Fig. 2-4).  In addition, peak 
bacteremia occurred 12 to 24 h later in male littermates than in females.  At the middle 
and late time points, however, differences in bacteremia between male and female 
littermates were not significant.  These data indicate a strong influence of gender on 
resistance to B. hermsii infection, particularly in the kinetics and effectiveness of early 
suppression of bacteremia. 
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Histopathology of infection.  
 To further characterize the course of B. hermsii infection in immunocompromised 
mice, we performed histopathological analysis of liver, spleen, and heart tissues from 
infected animals.  The liver and spleen were selected on the basis of their role as primary 
sites of bacterial clearance.  Additionally, in mice, liver and spleen are organs where 
ectopic hematopoiesis can occur.  We also collected heart tissue, to determine if this 
organ is a site of spirochetal invasion, given that carditis is a prominent feature of 
Borrelia burgdorferi and relapsing fever Borrelia infections (32, 93).   
 Liver, spleen, and heart tissues were collected from animals infected with 105 
CFU of DAH bacteria for various amounts of time.  Hepatosplenomegaly has been 
Figure 2-4.  Male rag2-/- mice are more 
susceptible than females to B. hermsii 
infection in the early stages of infection. 
(A) BALB/c rag2-/- males suffered more 
severe bacteremia than females of the same 
strain at the early time point (day 4 
postinfection).  Peak bacteremia in males 
occurred 12 to 24 h later than that of female 
mice.  (B) C57BL/6 rag2-/- males also 
suffered higher levels of bacteremia than 
female littermates at the early time point.  
However, bacteremia in C57BL/6 rag2-/- 
males was lower than that of BALB/c rag2-/- 
males at the same time point. Inset panels 
show peak bacteremia in the female cohorts 
only.  All experiments, n = 4; comparisons 
by two-tailed t test. 
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previously observed during B. hermsii infection of immunocompetent mice (6).  Indeed, 
necropsies of rag2-/- animals selected for tissue harvest revealed dramatic hepato- and  
 
splenomegaly at the late stages of infection in all strains examined. In addition, the 
spleens of BALB/c rag2-/- animals were more than two times larger than those of the 
C57BL/6 rag2-/- mice (data not shown).   
 Our histopathological analysis revealed that B. hermsii infection leads to the 
development of three processes that could contribute to splenomegaly.  There were no 
Figure 2-5.  Histopathology of 
infected rag2-/- mice.  Panels 
show H&E staining of liver (A) 
and spleen (B) sections of 
organs recovered from BALB/c 
rag2
-/- animals infected with 105 
CFU B. hermsii strain DAH 
bacteria.  Numerous RBCs were 
found in tissue-resident 
macrophages (box), indicating 
extensive erythrophagocytosis.  
The presence of megakaryocytes 
in spleens of infected animals 
indicates ongoing 
extramedullary hematopoiesis. 
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qualitative differences between spleens of rag2-/- mouse strains (data not shown), and to 
illustrate the results described below, we use representative images obtained using 
samples from BALB/c rag2-/- mice. First, analysis of H&E-stained sections revealed the 
expected influx of inflammatory cells in both livers and spleens of infected animals (Fig. 
2-5).  Second, spleens of infected animals had numerous megakaryocytes present (Fig. 2-
5B, arrow), indicating extensive extramedullary hematopoiesis.  Extramedullary 
hematopoiesis is often seen in chronic anemia and is consistent with the anemia of B. 
hermsii infection (Fig. 2-3A).  Third and most striking, all sections examined 
demonstrated extensive erythrophagocytosis by resident tissue macrophages.  Indeed, by 
day 6 postinfection, the majority of tissue macrophages contained large numbers of RBCs 
(Fig. 2-5A, box).  Thus, one of the developments in the progression of B. hermsii 
infection in immunocompromised mice may be removal of RBCs by tissue-resident 
macrophages, leading to anemia.  The extent of erythrophagocytosis in this 
nonquantitative assessment was similar in all inbred strains examined. 
 
Localization of spirochetes by fluorescent in situ hybridization. 
 To determine the level of tissue invasion by spirochetes during infection and 
whether the erythrophagocytosis observed upon histological analysis might be reflected 
in specific associations between spirochetes and RBCs, we visualized spirochetes 
in tissues using FISH with a Borrelia genus-specific probe.  FISH analysis revealed that 
by day 3 postinfection, spirochetes were found in all three of the tissues examined, i.e., 
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heart, spleen, and liver. In the heart, spirochetes were visualized associated with blood 
vessel walls, as well as with cardiac muscle, oriented parallel to the muscle fiber (Fig. 2-
6a, arrows).  In the liver and spleen, RBCs were identified on the basis of their anuclear 
and highly autofluorescent morphology (see also stacked RBCs in the cardiac blood  
  
Figure 2-6.  FISH analysis of the time course of B. hermsii infection.  B. hermsii 
spirochetes (orange [arrows and arrowheads]) could be detected in tissues (green 
background fluorescence) of infected BALB/c rag2-/- animals as early as 3 days 
after infection (a to c).  By day 6, the spirochetes could be found associated with 
anuclear cells (d to f, arrowheads) and blood vessel walls (d and e, arrows).  At the 
late stages of infection, numerous spirochetes were visible in cardiac muscle (g), 
liver (h), and spleen (i) tissue.  DAPI nucleic acid stain (blue) reveals the host cell 
nuclei. 
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vessel, Fig. 2-6d), and many spirochetes were observed associated with these cells (Fig. 
2-6a and b, arrowheads).  By day 6, the numbers of spirochetes found in each tissue 
increased despite a reduction in numbers of blood-borne bacteria (Fig. 2-2).  Spirochetes 
were readily seen associated with the blood vessel walls (Fig. 2-6d and e, arrows), and 
numerous spirochetes were observed wrapped around RBCs (Fig. 2-6d to f, arrowheads).  
By day 12 postinfection, B. hermsii numbers in the tissues increased further, correlating 
with the increased bacterial load in the blood and ultimately leading to severe infection 
and death of BALB/c rag2-/- and C3H rag2-/- animals.  In the heart, spirochetes were 
observed within the heart muscle (Fig. 2-6g), and in the liver and, particularly, in the 
spleen, there were numerous spirochetes associated with RBCs (Fig. 2-6h and i).  Thus, 
in addition to providing evidence that B. hermsii bacteremia is associated with significant 
invasion into tissues such as the heart, the results of our immunofluorescence 
examination indicate an association of spirochetes with RBCs, one that might underlie 
the extensive phagocytosis of red blood cells by tissue-resident macrophages. 
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Discussion 
  
 The genetic identity of the host plays a significant role in the control of a wide 
range of infectious diseases, from viral infections to colonization with parasites.  The 
tick-borne spirochete B. hermsii is extremely well adapted to growth in the bloodstream 
of infected hosts and may therefore serve as a model in which to study the mechanisms of 
clearance of bacterial pathogens from the bloodstream.  Although the analysis of B. 
hermsii infection has provided important insights into how bloodborne pathogens trigger 
a host immune response, particularly a robust antibody response, no studies of the 
contribution of the genetic component of the host to the course and outcome of B. hermsii 
infection have been performed.  In the current study, by analyzing the course of B. 
hermsii infection in inbred strains of mice, we established that in fact, in the absence of a 
humoral response, the innate immune system is capable of partial control of B. hermsii 
infection.  In addition, we found that the genetic background of the host contributes 
significantly to the severity of both bacteremia and anemia, prominent manifestations of 
infection. 
 To begin our analysis, we selected 5 common inbred commercially available 
mouse strains that have previously been demonstrated to display differential patterns of 
sensitivity to various pathogens (55).  Our survey revealed significant strain specific 
differences in the progression of infection, in that bacteremia was 6-fold more severe in 
C57BL/6ByJ than in BALB/cByJ animals at day 3 after infection (Fig. 2-1).  The high 
statistical significance (P < 0.01) of this finding suggests that inbred mouse strains are 
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sufficiently different in clearing B. hermsii from the bloodstream to allow for the 
identification of the genetic polymorphisms that likely account for this differential 
susceptibility.   
 It is well established that adaptive immunity, particularly a T-cell-independent 
antibody response, is critical for clearance of relapsing fever spirochetes.  To determine if 
genetic differences in innate immunity contribute to the differences in susceptibility to 
infection that we observed in immunocompetent strains, we followed the course of B. 
hermsii infection in an analogous set of strains carrying a rag2 deletion.  Rag2 knockout 
mice, like scid and rag1-/- animals, lack specific immunity, but their innate immunity is 
intact (139).  We found that rag2-/- mice had higher levels of circulating spirochetes at the 
initial peak of bacteremia than their immunocompetent counterparts.  This is likely due to 
a combined contribution of innate and adaptive immunity to the early response to B. 
hermsii infection in immunocompetent mice.  Rapid response to B. hermsii early in the 
infection can be mediated by both marginal zone (MZ) B and B1 cells (2, 18).  These T-
cell-independent B-cell subsets can differentiate into plasmablasts within 48 h after 
exposure to bacteria or bacterial products and are therefore capable of generating a 
significant specific-antibody response, required for controlling bacterial burden, by 3 
days postinfection (8, 98).  Consistent with the results of our previous work with 
immunocompromised (rag1-/-) mice, none of the animals fully cleared the infection, but 
each was capable of diminishing the bacterial load from an early peak, indicating that 
innate immune mechanisms were functioning to control infection (Fig. 2-2) (3).  In 
addition, consistent with the relative susceptibility of immunocompetent C3H mice, C3H 
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rag2
-/- mice did not control the initial peak of bacteremia as well as BALB/c rag2-/- mice, 
indicating that at least in part, the susceptibility of wild-type C3H rag2-/- mice reflects a 
relative defect in innate immunity.  Interestingly, in direct contrast to the relative 
susceptibility of immunocompetent C57BL/6ByJ mice, female C57BL/6 rag2-/- mice 
were able to control the initial peak of bacteremia as well as BALB/c mice.  Because 
these C57BL/6 mice are separated from their common progenitors by many generations, 
it is possible that the different patterns of response to B. hermsii infection of 
immunocompetent and immunocompromised mice are due to subline-specific genetic 
differences.  In fact, we recently described C57BL/6 subline-specific differences in 
response to L. monocytogenes infection (61).  Nevertheless, the detrimental effect of 
adaptive immune cells on innate immune function has been documented for the mouse 
model of L. monocytogenes infection (33).  Therefore, it is possible that although the 
combined efforts of the innate and adaptive immune systems of wild-type C57BL/6 mice 
are capable of completely clearing B. hermsii infection, the innate immune response to B. 
hermsii by these mice is impaired at the early stages of infection.   
 The gender of the host can often influence susceptibility to infectious disease.  In 
addition to the relevance of such sex specific phenotypes for understanding the 
pathogenesis of infection, for genetic studies it is important to know if the phenotype can 
be analyzed using entire cross populations or if the animals have to be segregated 
according to sex.  To test the effect of gender, we compared the progression of B. hermsii 
infection in male and female C57BL/6 rag2-/- and BALB/c rag2-/- animals.  For both 
strains, males had significantly higher and somewhat delayed initial peaks of bacteremia 
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compared to the initial peaks in female animals, indicating that the gender of the host 
plays a substantial role in control of B. hermsii bacteremia.  While it would be difficult to 
test directly if similar gender-specific differences in susceptibility to relapsing fever exist 
in the human population, our observation provides a starting point for research in this 
direction.   
 In addition to bacteremia, relapsing fever patients commonly suffer from anemia 
and thrombocytopenia.  The etiology of these changes in blood cell counts is not 
understood and could be multifactorial, but it is tempting to speculate that the proximity 
of these cells to high concentrations of bacteria in the blood promotes interactions that 
lead to host cell clearance.  Indeed, episodes of thrombocytopenia correspond temporally 
with peaks of bacteremia, and the spirochetes bind to circulating platelets during 
infection (5).  In addition, both Borrelia crocidurae and B. hermsii have been shown to 
bind to erythrocytes in vitro and in blood samples from infected animals (30, 68).  Our 
examination of tissues provided data that support the hypothesis that the interaction of 
spirochetes with cellular components of blood influences the number of circulating cells. 
We found that liver-resident macrophages (Kupffer cells) contain significant numbers of 
phagocytosed and highly clustered RBCs (Fig. 2-5), and FISH analysis demonstrated that 
RBCs are frequently associated with spirochetes, some of which appear to wrap around 
the entire periphery of the cell (Fig. 2-6).  These findings, along with the kinetics of 
anemia, are consistent with a speculative model in which RBC binding might contribute 
to the ability of animals to control bacteremia.  According to this model, bacteremia is 
associated with spirochete-RBC interactions, leading to RBC clearance by 
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erythrophagocytosis, either due to RBC damage or to “bystander” clearance of RBCs 
stably bound to spirochetes.  The phagocytosis of spirochetes and RBCs leads to 
hepatosplenomegaly, as well as to a decrease in bacteremia by day 6 of infection.  This is 
followed by a partial recovery in RBC count as hematopoiesis (including extramedullary 
hematopoiesis) occurs, and a period of relatively consistent anemia and bacteremia. 
However, late in infection, e.g., by day 11 or 12, perhaps as the erythropoietic and/or 
phagocytic capacities of infected animals become exhausted, decreasing numbers of 
circulating RBCs and increasing numbers of blood-borne spirochetes are observed, 
leading to the terminal phase of infection.  Thus, one might imagine that RBCs play a 
role in the initial control of B. hermsii infection by acting as a “sink” for circulating 
bacteria.  Bergstrom and colleagues have suggested that RBC binding by B. crocidurae 
promoted a delay in the development of an adaptive immune response (30), and these 
models are not mutually exclusive. 
 Our results indicate that innate immunity plays a significant role in the control of 
B. hermsii replication and that this contribution is different in inbred mouse strains.  In 
addition, our study lays the groundwork for a future thorough, unbiased genetic analysis 
of differential responses to B. hermsii infection in inbred mouse strains that will identify 
critical control elements in the regulation of innate immunity.  Analysis of these elements 
will improve our understanding of innate immune response to blood-borne pathogens.  In 
addition, since innate immunity contributes to defense against a wide range of pathogens, 
these findings are likely to contribute to our understanding of general mechanisms of 
host-pathogen interactions. 
46 
 
Acknowledgements 
 
This chapter was adapted from Benoit, V.M., Petrich, A., Alugupalli, K.R., Marty-Roix, 
R., Moter, A., Leong, J.M., and Boyartchuk, V.L.  (2010) Genetic control of the innate 
immune response to Borrelia hermsii influences the course of relapsing fever in inbred 
strains of mice.  Infection and Immunity. 78(2): 586-594.  David Garlick provided helpful 
suggestions and interpretation of the histopathology results. 
47 
 
CHAPTER III 
 
Allelic variation of DbpA of the Lyme disease spirochete 
influences binding to decorin, dermatan sulfate, and 
cultured epithelial cells  
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Abstract 
 After transmission by an infected tick, the Lyme disease spirochete, Borrelia 
burgdorferi sensu lato, can colonize the mammalian skin and often disseminates 
systemically.  The three major species of Lyme disease spirochete, B. burgdorferi sensu 
stricto, B. garinii and B. afzelii, are associated with different chronic manifestations of 
infection. Chronic colonization of multiple tissues is likely promoted by the ability to 
bind to components found in target tissues, and Lyme disease spirochetes utilize multiple 
adhesive molecules to interact with diverse mammalian components. The allelic variable 
surface lipoprotein decorin binding protein A (DbpA) promotes bacterial binding to the 
proteoglycan decorin and the glycosaminoglycan (GAG) dermatan sulfate.  To assess 
allelic variation in the GAG-, decorin- and cell-binding activities of DbpA, we expressed 
different DbpA alleles in B. burgdorferi strain B314, a high-passage, noninfectious, that 
lacks dbpA and is not capable of binding mammalian cells. The alleles tested include 
representatives of B. burgdorferi sensu stricto, B. garinii and B. afzelii. Each of the DbpA 
alleles conferred upon B. burgdorferi strain B314 the ability to bind to cultured kidney 
epithelial (but not glial or endothelial) cells, as well as to purified decorin and dermatan 
sulfate.  Nevertheless, allelic variation of DbpA was associated with dramatic differences 
in substrate binding activity. Whereas in most cases decorin and dermatan sulfate binding 
correlated well, one DbpA allele promoted differential binding to decorin and dermatan 
sufate, indicating that the two activities are not identical.  Another allele with relatively 
low adhesive activity is derived from a strain that is known to cause disseminated 
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infection in mice, indicating that robust DbpA-mediated adhesive activity is not required 
for spread in the mammalian host.  
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Introduction 
 
 Lyme disease spirochetes of the genus Borrelia are transmitted to humans from a 
bite by an infected Ixodes tick.  Transmission of spirochetes to humans from the infected 
tick can result in a local infection of the skin, typically giving rise to a characteristic rash 
termed erythema migrans.  In the absence of antibiotic therapy, some strains may 
disseminate from the skin, via the blood , to multiple secondary sites including joints, 
heart, and brain, resulting in the varied clinical manifestations of Lyme disease such as 
arthritis, carditis and neuroborreliosis (for review, see (142)). 
 At least seven species of Borrelia are associated with Lyme disease (43, 63, 125, 
129, 142), and are collectively referred to as B. burgdorferi (sensu lato).  The three most 
common Lyme disease spirochetes are B. burgdorferi (sensu stricto), B. garinii and B. 
afzelii.  B. burgdorferi (sensu stricto), herein referred to simply as B. burgdorferi, is the 
most prevalent Lyme disease spirochete in the United States. In Europe all three species 
are associated with Lyme disease B. garinii and B. afzelii predominate.   The three 
species are each capable of causing long-term infection in humans, but are associated 
with different chronic manifestations: B. burgdorferi with Lyme arthritis, B. garinii with 
neuroborreliosis, and B. afzelii with the chronic skin lesion acrodermatitis (157).  
Additionally, within a species, there is apparently strain-to-strain variation in the ability 
to cause disseminated infection (155, 163). B. burgdorferi strains, typed on the basis of 
polymorphisms in the rRNA operon or the highly polymorphic ospC gene, have been 
shown to vary in their association with bloodstream infection in humans (53, 158, 162).  
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Although OspC, a surface lipoprotein, is required for experimental infection of the mouse 
(65), allelic variation of OspC cannot fully account for observed differences in the 
capacity to disseminate within the mammalian host by various B. burgdorferi strains (1).  
Thus, other virulence factors likely contribute to the apparent differences in tissue 
colonization and clinical manifestations exhibited by diverse Lyme disease spirochetes. 
  Attachment to host tissues is thought to be a critical step in the ability of many 
pathogens to disseminate within the mammalian host.  B. burgdorferi attaches to a wide 
variety of cells in vitro including epithelial, endothelial and glial cells, platelets and 
lymphocytes (45, 49, 59, 60, 147, 148).  In addition, multiple host cell and extracellular 
matrix molecules are recognized by B. burgdorferi such as integrins (39), fibronectin (24, 
64, 118), laminin (25, 152), collagen (171), and proteoglycans (67, 78, 86).  
Proteoglycans consist of a protein core covalently linked to one or more 
glycosaminoglycan (GAG) chains, which are long linear repeating disaccharides (for 
review, see (94)).  GAGs are typically quite heterogeneous in size and vary structurally 
between tissues and host species (116).  Different GAGs can be segregated into classes 
based on epimerization of the glycan chain, location and degree of sulfation, and 
sensitivity to enzymatic cleavage by different lyases. 
 We previously showed that diverse spirochetes recognize distinct classes of 
GAGs, and differences in GAG-binding specificity can lead to differences in the types of 
mammalian cells recognized (113).  For example, B. burgdorferi N40 strain, which 
recognizes heparan sulfate and dermatan sulfate GAGs, binds efficiently to glial and 
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endothelial cells in vitro, while B. afzelii strain VS461, which predominately recognizes 
dermatan sulfate, binds selectively to glial cells (113).  These findings suggest that strain 
specific differences in GAG recognition by Lyme disease spirochetes might influence the 
specificity of host cell attachment and thus tissue colonization during infection. 
 B. burgdorferi encodes multiple GAG binding proteins, including the highly 
related decorin binding proteins (Dbp) A and B, which were first identified on the basis 
of their ability to bind decorin, a chondroitin/dermatan sulfate proteoglycan that 
“decorates” collagen fibers in mammalian tissues (66, 67, 70).  These proteins, when 
expressed in a noninfectious and otherwise nonadherent B. burgdorferi strain, were 
shown to be sufficient to promote spirochetal attachment to isolated dermatan sulfate 
GAGs as well (57).  The dbpA (and presumably dbpB) gene is not expressed in the unfed 
tick, but transcription is induced upon tick feeding (75).  In addition, DbpA and B are 
required for maximal infectivity and dissemination in both immunodeficient and 
immunocompetent mice (21, 138, 160).  These findings are consistent with the 
hypothesis that spirochetal binding to extracellular matrix mediated by DbpA and DbpB 
promotes colonization of the mammalian host. 
 DbpA and DbpB are related proteins that each bind to dermatan sulfate, but differ 
in their GAG and mammalian cell type binding specificities (57).  In addition, while 
DbpB is highly conserved among Lyme disease spirochete strains, DbpA is highly 
polymorphic (123), and recombinant derivatives of DbpA allelic variants differ in decorin 
binding (115).  In this study, we found that allelic variation of DbpA is associated with 
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dramatic differences in the ability of this adhesin to promote bacterial attachment to 
GAGs and mammalian cells.  
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Experimental procedures 
Bacterial strains and cells lines.  The high-passage B. burgdorferi strain B314 (128) 
was the generous gift of Tom Schwan (Rocky Mountain Labs, Hamilton, MT).  B. 
burgdorferi strains N40 clone D10/E9 (“N40D10/E9”), B356, B31, and 297, B. garinii 
strain PBr, and B. afzelii strain VS461 have been described previously (39, 58).  B314 
and its derivatives were cultured at 33°C in BSKII complete medium (10), supplemented 
with 200 g/ml kanamycin where appropriate.  For a list of bacterial strains used in this 
study, see Table 3-1.  293 (human kidney epithelial) cells, C6 (rat glioma), and EA-hy926 
(human umbilical vein endothelial) cells were cultured as described previously (113). 
      
 
Table 3-1.  Bacterial strains used /generated in this study. 
 
56 
 
Plasmids and cloning.  For initial sequence analysis, dbpA from B. burgdorferi strains 
N40, B356, B31 and 297, from B. afzelii strain VS461 and from B. garinii strain PBr 
were amplified by PCR from genomic DNA using primers and reaction conditions 
described previously (123).  Briefly, the forward primer, 10F4 5’-
GTGGTTAAGGAAAAACAAAA-3’, is homologous to a sequence in the highly 
conserved dbpB gene (123), and the reverse primer, 5R1 5’-
CCAAATAACATCAAAAAGGA-3’, is homologous to a sequence downstream of dbpA.  
PCR with these primers resulted in the generation of amplicons approximately 1kb in 
size, which were inserted into pCR-XL-TOPO vector (Invitrogen) and then sequenced.  
Nucleotide sequence analysis showed that dbpA cloned from strains B31, 297, PBr and 
VS461 were identical to previously published sequences (123, 164). DbpA from strain 
N40D10/E9 was found to be 95% identical to DbpA from an independent clone of N40 
(123)  and is for clarity referred to as DbpAN40-D10/E9 in this study.  
 For expression in strain B314, each dbpA allele was amplified from genomic 
DNA by PCR using primers listed in Table 1 from the transcription initiation codon to its 
cognate termination codon.  These amplicons were then cloned into a modified shuttle 
vector, pJF21, (57) using engineered SalI and BamHI sites at the 5’ and 3’ ends 
respectively, and sequenced with M13F and M13R primers.  For production of 
recombinant proteins, dbpA from strains B31, N40D10/E9, PBr, and VS461, minus their 
lipoprotein signal sequences, were amplified by PCR using primers described in Table 3-
2 and cloned into pET15b (Novagen, Madison, WI).  
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Purification of human decorin.  Recombinant human decorin, a generous gift from 
David Mann (MedImmune, Inc.), was purified from stably transfected Chinese hamster 
ovary cells as described (77). 
Generation of recombinant proteins and antisera.  Plasmids encoding recombinant 
His-tagged DbpA proteins were transformed into E. coli BL21, and protein expression 
was induced with 1mM IPTG.  Bacteria were lysed and proteins were purified by nickel 
affinity chromatography as described in the manufacturer’s instructions (Novagen).  Five 
week old Balb/C mice were immunized with 100 g of His-DbpAB31, His-DbpAN40-D10/E9, 
Table 3-2.  Primers used in this study.  Underlined sequences denote restriction sites. 
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His-DbpAPBr, or His-DbpAVS461 in complete Freund’s adjuvant.  The animals were 
boosted twice with 100 g of the same proteins in incomplete Freund’s adjuvant at two 
week intervals and antisera were prepared after terminal cardiac puncture.    
Attachment of immobilized recombinant DbpA proteins to biotinylated 
glycosaminoglycans.  Dermatan sulfate (Calbiochem), heparin and chondroitin-6-sulfate 
(Sigma) were biotinylated using EZ-Link Biocytin Hydrazide (Pierce) and then dialyzed 
in PBS using a Slide-A-Lyzer cassette (Pierce) with 10,000 kD MW cutoff.  96-well 
microtiter plates (Linbro) were coated overnight at 4°C with 1 g of his-tagged 
recombinant DbpA in PBS.  The next day, proteins were removed and wells were washed 
twice with PBS and then blocked with 1% BSA in PBS for 1 hour at room temperature.  
Blocking buffer was removed and 50 l of each biotinylated GAGs, diluted to a final 
concentration of 100 g/ml 1% BSA in PBS, was added to wells and incubated for 2 
hours.  After washing, bound GAGs were detected by ELISA using horseradish 
peroxidase tagged anti-biotin antibody. 
Transformation of B. burgdorferi B314.  Electrocompetent B314 spirochetes were 
prepared and transformed as described (103).  Briefly, 100 ml of mid-log phase cultured 
spirochetes were harvested and washed twice in electroporation solution (EPS, 15% v/v 
glycerol, 0.27M sucrose) and resuspended in 100l of EPS.  30-40 g of plasmid DNA 
was added to the suspension and electroporated at 2200 volts in a 0.2cm cuvette, and then 
cultured in BSKII complete medium at 33°C for 24 hours.  The transformation mix was 
added to 1.7% analytical grade agarose (Invitrogen) and plated onto a 1.5X 
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BSKII/agarose bottom layer in a sterile 100 X 20 tissue culture dish (Corning) in the 
presence of kanamycin (200 g/ml), and plates were incubated at 34°C in a 2% CO2 
atmosphere for 2 weeks.  Colonies were picked and cultured at 33°C to mid-log phase 
density in BSKII complete medium containing kanamycin (200 g/ml). 
Proteinase K treatment, SDS-PAGE and Western blotting.  To detect DbpA proteins, 
lysates from 5 X 107 spirochetes were separated by 15% SDS-PAGE.  DbpA and FlaB 
were identified by immunoblotting using polyclonal antibodies against the appropriate 
DbpA (diluted 1:5000) or a monoclonal antibody, CB1 (a gift from J. Benach, Stony 
Brook University, Stony Brook, NY) against FlaB (diluted 1:500), respectively.  Surface 
localization of DbpA proteins in recombinant B314 strains was determined as previously 
described (118).  Briefly, 5 X 107 spirochetes were centrifuged and pellets were washed 
twice in PBS + 2% BSA.  After the final wash, pellets were gently lifted with 5mM 
MgCl2 in PBS supplemented with 4 mg/ml Proteinase K (Sigma) or buffer only and 
incubated at room temperature for 30 minutes.  To inactivate Proteinase K, 150 g of 
phenylmethylsuphonyl fluoride (PMSF) was added to each pellet.  Pellets were washed 
twice with PBS + 0.2% BSA, lysed and separated by 15% SDS-PAGE.  DbpA proteins 
were identified by immunoblotting as described above. 
Triton X-114 fractionation.  Membrane fractions of B314 expressing DbpA were 
prepared as described previously (23).  Briefly, Borrelia cultures were grown to log 
phase as determined by counting spirochetes by darkfield microscopy and 109 spirochetes 
were harvested and washed twice with 0.2% BSA in PBS.  Spirochetes were then 
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resuspended in 2% Triton X-114 and allowed to incubate overnight with rocking at 4°C.  
The following day, insoluble material was removed by centrifugation and supernatants 
were phase separated as follows:  Supernatants were warmed to 37°C for 15 minutes, and 
then centrifuged at 13,000 rpm for 15 minutes to separate the aqueous and detergent 
fractions.  The aqueous phase was discarded and the detergent phase was washed three 
times by adding cold PBS to original volume and rewarming and recentrifuging as above 
in the phase separation step.  After the final wash, proteins were precipitated by adding 9 
volumes of cold 100% ethanol, incubating overnight at -20°C, and recovered by 
centrifugation.  After washing with 90% ethanol, proteins were resuspended in PBS.  
Protein concentration was determined by BCA assay (Pierce).  15 g of total protein from 
the outer membrane (detergent) fraction was then separated on a 15% SDS-PAGE gel 
and stained with Coomassie blue.              
Attachment of spirochetes to mammalian cells.  Radiolabled bacteria were prepared by 
growing spirochetes at 33°C in BSKII complete medium supplemented with 60 Ci/ml of 
(35S)-methionine.  When cultures achieved mid-log phase (approximately 5 X 107/ml), 
bacteria were harvested at 10,000 X g and pellets were washed twice with 0.2% BSA in 
PBS.  Labeled spirochetes were then stored as aliquots at -80°C in BSK-H (Sigma) 
containing 20% glycerol.  
 One day before each assay, mammalian cells were lifted with 0.5% trypsin, 
0.5mM EDTA (Invitrogen) and plated in 96-well break-apart microtiter plates (Nunc) 
which were previously UV-sterilized and coated with MBP-Inv497, a maltose binding 
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protein fusion containing the cell binding domain of the invasion protein from Y. 
pseudotuberculosis (85).  Frozen aliquots of radiolabeled B. burgdorferi were thawed and 
resuspended at 1 X 108 cells/ml in BSK-H and incubated at room temperature for 2 hours.  
Prior to addition of radiolabeled spirochetes, cell monolayers were washed twice with 
PBS.  Radiolabled spirochetes were then diluted 1:3 into GHS buffer (10mM glucose, 
10mM hepes, 50mM NaCl, pH 7.0) and added in quadruplicate wells at 1 X 106 
spirochetes/well.  To enhance spirochete-cell contact, plates were centrifuged at 1000 
rpm for 5 minutes and then rocked at room temperature for 1 hour.  Unbound spirochetes 
were removed by washing wells four times with 0.2% BSA in PBS.  Plates were then air-
dried and the percentage of bound bacteria in each well was determined by liquid 
scintillation.  Each strain was tested for cell binding in three to five independent 
experiments.   
Enzymatic removal of specific classes of GAGs.  Monolayers were incubated for 2 
hours with 0.5U/ml heparinase I, heparitinase, or chondroitinase ABC (Sigma) at 37°C in 
RPMI supplemented with 1% BSA, 10-2 TIU/ml aprotinin and 165 g/ml PMSF.  After 
washing the monolayers with PBS, radiolabeled spirochetes were added to pretreated 
monolayers as described above. 
Inhibition of binding with exogenous GAGs.  Radiolabeled spirochetes were prepared 
as described above and were incubated for 30 minutes at room temperature in BSK-H 
supplemented with between 80 ng/ml and 6.25 mg/ml GAGs.  Following incubation, 
spirochetes were diluted 1:3 in GHS buffer before addition to cell monolayers. 
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Attachment of radiolabeled bacteria to purified GAGs and decorin.  Prior to each 
assay, wells from Nunc 96-well break-apart microtiter plates were coated with either a 
titration of purified human decorin (1.25-0.156 g/ml) or dermatan sulfate (2.5-0.625 
mg/ml) in PBS at 4°C overnight.  Wells were washed 3 times with 0.05% Tween-20 in 
PBS.  Wells were then blocked with 1% BSA in PBS for 1 hour at room temperature. 
After removal of the blocking buffer, radiolabeled B. burgdorferi were added to the wells 
as described above.     
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Results 
Ectopic expression of diverse DbpA alleles on the surface of a non-adherent B. 
burgdorferi strain.   
 We previously showed that recombinant DbpA from B. burgdorferi strain N40 
clone D10/E9 (N40D10/E9) bound to purified GAGs (57, 84).  To determine if GAG 
binding activity is a common property of diverse DbpA alleles, here we examined DbpA 
from a variety of Lyme disease spirochetes.   B. burgdorferi strain B31 is the type strain 
for this organism (58), B. garinii strain PBr displays high levels of the hemagglutination 
activity that is associated with GAG binding (86), and strain VS461 is a representative of 
B. afzelii (97). DbpA from strain N40D10/E9 was found to be 95% identical to DbpA from 
an independent clone of N40 (123)  and for clarity is referred to here as DbpAN40-D10/E9. 
These DbpA alleles share as little as 62% identify (Table 3-3; Fig. 3-2).   
 
Table 3-3.  DbpA alleles 
used in this study.  A 
pairwise comparison of 
amino acid identities 
between DbpA alleles is 
shown.  B.b. = Borrelia 
burgdorferi, B.g. = Borrelia 
garinii, B.a. = Borrelia 
afzelii. Dotted lines indicate 
groups of alleles which 
share significant homology.  
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Figure 3-2.  Amino acid alignment of DbpA alleles used in this study.    
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Immobilized recombinant DbpA alleles were tested for their ability to bind to 
biotinylated GAGs.  DbpA from each strain bound to heparin as well as to dermatan 
sulfate, but not to a control GAG, chondroitin-6-sulfate (Fig. 3-1).  
 
 
   
 
 
Some differences in the apparent efficiency of GAG binding were noted among the 
different DbpA alleles, suggestive of allele-specific differences in GAG binding activity.   
 Given that it is not clear how faithfully the ability of recombinant DbpA to bind 
GAGs reflects the activity of DbpA when expressed on the spirochetal surface, we next 
tested the adhesive function of DbpA alleles on the surface of B. burgdorferi, taking 
Figure 3-1.  Recombinant DbpA proteins bind to biotinylated GAGs.   
Microtiter wells were mock-coated (with PBS) or coated with His-tagged DbpAN40, DbpAB31, 
DbpAPBr, and DbpAVS461 proteins were probed with biotinylated heparin, dermatan-sufate or 
chondroitin-6-sulfate (see Materials and Methods).  After washing, bound GAGs were 
detected by ELISA using -biotin antibody conjugated to horseradish peroxidase and 
colorimetric substrate (TMB).  Binding is reflected by absorbance at 450 nm.  Each bar 
represents the mean of four independent determinations  SD.  [Asterisks indicate binding 
was significantly (p < 0.05, student’s t test) higher than binding to mock-coated wells.]   
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advantage of the fact that ectopic expression of DbpAN40 is sufficient to confer 
spirochetal adhesiveness (128). B. burgdorferi strain B314 is a high passage strain that 
lacks all discernible linear plasmids, including lp54, which encodes the dbpBA operon, 
and appears to be incapable of binding to GAGs or cultured mammalian cells. Alleles of 
dbpA were cloned into the expression shuttle vector pJF21 3’ to the ospC promoter (57, 
144), which is highly active in strain B314 and is predicted to facilitate high-level 
transcription (128). Recombinant plasmids were then transformed into B. burgdorferi 
strain B314. In addition to the alleles of B. garinii PBr, B. afzelii VS461, and B. 
burgdorferi N40D10/E9 and B31, we also analyzed dbpA from B. burgdorferi 297, a 
commonly studied strain, and from B. burgdorferi B356, a skin biopsy isolate that is 
incapable of causing persistent disseminated infection in mice(155)  To confirm that 
these DbpA alleles were expressed in strain B314, bacterial outer membrane proteins 
were isolated by Triton X114 extraction and immunoblotted using mouse anti-DbpA 
antisera.  As expected, each recombinant strain harboring a recombinant plasmid 
encoding dbpA was found to produce DbpA, whereas B314 harboring the pJF21 vector 
control did not (Fig. 3-3A).  Proteinase K digestion of intact spirochetes resulted in 
complete or near-complete loss of reactivity to DbpA antisera in immunoblot analysis, 
indicating that all DbpA alleles were exported to the surface of strain B314.  As 
predicted, the periplasmic protein FlaB remained intact, indicating the integrity of the 
outer membrane during Proteinase K digestion (Fig. 3-3B). 
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DbpA displays allelic variation in the recognition of dermatan sulfate on the surface 
of cultured epithelial cells.   
 DbpAN40-D10/E9 was previously shown to promote attachment to cultured epithelial 
cells but not to endothelial nor glial cells (57).  Therefore, recombinant B314 strains 
Figure 3-3.  DbpA alleles from diverse Lyme disease spirochetes are expressed on the 
surface of a non-adherent B. burgdorferi strain.   
A) Triton X-114 extractions of B. burgdorferi strain B314 expressing the indicated DbpA allele 
were subjected to 15% SDS-PAGE and immunoblotted with a mixture of antisera raised against 
DbpAB31, DbpAN40, DbpAPBr, and DbpAVS461.   
B) Spirochetes expressing DbpA protein were digested with Proteinase K (pK) or incubated in 
PBS (Mock).  Lysates from 5 X 107 treated bacteria were separated by 15% SDS-PAGE and 
DbpA and FlaB proteins were identified by Western blot.  The detection of a Proteinase K-
resistant band in B314/pDbpAB356 and B314/pDbpAN40 is a consistent finding and may represent 
intracellular DbpA protein that has not been lipidated.  Flagellin, a periplasmic protein, was 
blotted for as a control.  §This strain was analyzed in a separate experiment. 
  
 
§ 
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expressing different DbpA alleles were tested for gain-of-function in attachment to 293 
epithelial, EA-Hy926 endothelial, and C6 glial cells. Similar to our previous analysis of 
DbpAN40-D10/E9, all DbpA alleles promoted spirochete attachment to cultured epithelial 
cells but not glial (Fig. 3-4) or endothelial cells (data not shown).  
 
      
DbpAPBr promoted the highest levels of attachment to epithelial cells. DbpA297 and 
DbpAB31 mediated spirochetal binding less efficiently than DbpAPBr, but more efficiently 
than DbpAN40-D10/E9, DbpAB356 and DbpAVS461.  Complementation of the non-adherent 
strain B314 gave reproducible results across multiple assays, and independently derived 
clones expressing the same allele, either DbpAN40-D10/E9 or DbpAVS461, displayed similar 
binding to 293 epithelial cells, purified decorin and dermatan sulfate (Fig. 3-5). These 
results suggested that the binding phenotype measured in this way reflected the allele 
rather than the particular clone analyzed.  
Figure 3-4.  DbpA-mediated 
binding to cultured mammalian 
cells is variable among alleles 
and is cell type specific.                 
Radiolabeled B.burgdorferi strain 
B314 spirochetes expressing the 
indicated DbpA allele were added 
to wells containing 293 epithelial 
cells, C6 glioma cells or no cells.  
Each bar represents the mean (± 
standard deviation) of four 
independent determinations with 
background binding (B314 
expressing no DbpA) subtracted.  
Asterisk indicates that this 
strain was analyzed in a 
separate experiment.   
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 To determine if GAGs promoted binding of the recombinant B314 strains to 293 
cells, monolayers were digested with specific lyases to remove different classes of GAGs 
from the cell surface.  We previously showed that spirochetal binding to 293 cells 
mediated by DbpAN40-D10/E9 required dermatan sulfate (57).  Consistent with this, removal 
of dermatan/chondroitin sulfates with chondroitinase ABC virtually eliminated 
attachment promoted by all DbpA alleles, where as removal of heparin/heparan sulfates 
with heparinase or heparitinase had no significant effect (Table 3-4).   
Figure 3-5.  Independently derived clones expressing the same allele of DbpA display 
similar in vitro binding phenotypes.   Radiolabeled B.burgdorferi strain B314 
spirochetes expressing the indicated DbpA allele were added to wells containing A) 293 
epithelial cells, or no cells; or B) decorin, dermatan sulfate or PBS (mock) coated wells.  
Each bar represents the mean (± standard deviation) of four independent determinations. 
 
70 
 
 
In addition, exogenous dermatan sulfate, but not heparin or chondroitin-6-sulfate, 
significantly impaired cell binding by recombinant B314 strains expressing DbpA from 
strains B356, 297 or PBr (Table 3-5), suggesting that cell attachment was associated with 
GAG binding activity.  
 
Table 3-5.  DbpA alleles 
from diverse Lyme disease 
spirochetes specifically 
recognize dermatan sulfate 
on epithelial cells. 
 
Table 3-4.  GAG-binding 
by DbpA alleles from 
diverse Lyme disease can 
be inhibited by cleavage of 
chondroitin sulfate GAGs 
from the surface of 
epithelial cells. 
 
* 
* 
* 
* 
* 
* 
* 
* 
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DbpA displays allelic variation in the ability to promote spirochetal attachment to 
purified decorin or dermatan sulfate.   
 We found previously that DbpAN40 was able to confer binding to purified 
dermatan sulfate to strain B314 (57).  To determine whether the variation in the ability of 
different DbpA alleles is associated with differences in their ability to promote binding to 
purified GAGs, we tested for binding of the recombinant B314 strains to microtiter wells 
coated with increasing concentrations of dermatan sulfate.  Of all the DbpA-expressing 
strains, B314 expressing DbpAPBr bound most efficiently to dermatan sulfate at all 
concentrations tested (Fig. 3-6, right panel).  DbpA297 and DbpAB31 promoted binding 
somewhat less efficiently than DbpAPBr, but more efficiently than DbpAVS461, DbpAB356, 
or DbpAN40-D10/E9 (Fig. 3-6 right panel).  Binding mediated by the latter three alleles, 
while not robust, was nevertheless well above the background levels observed for strain 
B314 harboring control vector. Thus, variation in the ability of the DbpA alleles to 
promote binding to purified dermatan sulfate correlated with their ability to promote 
binding to 293 cells (compare Figs. 3-4 and 3-6 right panel), suggesting that 293 cell 
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attachment reflects dermatan sulfate binding activity. 
 
 
 
  
 DbpA was originally identified by its ability to bind to decorin, a dermatan sulfate 
proteoglycan (66).  To test whether allelic variation of DbpA in binding to decorin 
correlates with binding to dermatan sulfate, the B314 recombinants expressing different 
DbpA alleles were similarly tested for the ability to bind to increasing concentrations of 
immobilized decorin.  As above, B314 expressing DbpAPBr bound most efficiently to 
decorin, and DbpA297 and DbpAB31 promoted attachment to decorin more efficiently than 
DbpAB356 or DbpAN40-D10/E9 (Fig. 3-6 left panel). Notably, DbpAVS461 promoted relatively 
efficient binding to decorin, in spite of promoting only low level binding to dermatan 
sulfate and epithelial cells (compare to Fig. 3-6, left panel and right panel, and Fig. 3-4). 
These results indicate that DbpA-mediated bacterial attachment to decorin and dermatan 
Figure 3-6.  Decorin- and GAG-binding levels vary among DbpA alleles.  
Radiolabeled B314 spirochetes harboring the indicated plasmid were added to 
wells coated with increasing concentrations of decorin or dermatan sulfate, and the 
percent of bacteria stably bound was determined.  (Asterisk indicates that the 
experiments for B314 expressing DbpAB31 were performed in a separate 
experiment.)  Each point represents the mean of four independent determinations.  
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sulfate are distinguishable, with binding to purified dermatan sulfate correlating better 
with 293 epithelial cell binding.  
   
The C-terminus of DbpAVS461 is required for spirochetal attachment to mammalian 
cells and to purified decorin or dermatan sulfate. 
 Basic amino acids are often critical for the ability of GAG-binding proteins to 
bind their substrate (73), and three lysine residues of DbpA297, K82, K163 and K170, were 
previously identified by chemical modification and mutagenesis as critical for decorin 
binding (26).  In addition, synthetic DbpA297 peptides encompassing either K82 or both 
K163 and K170 directly bound to decorin (115).  Höök and coworkers previously showed 
that the peptides encompassing K82 and corresponding to diverse DbpA alleles were 
each capable of inhibiting binding of the parental DbpA allele to decorin, implicating this 
region in decorin binding by diverse alleles. In addition, the sequences flanking K82 of 
DbpAB31 or DbpAN40, which differed significantly in their ability to promote binding to 
epithelial cells, dermatan sulfate and decorin (Fig. 3-3 and 3-4), are nearly identical (Fig. 
3-7), suggesting that other segments of the proteins may contribute to GAG, decorin and 
cell binding. We assessed the potential function of the C-terminus of a B. afzelii strain by 
deleting the DbpAVS461 C-terminal 11 amino acids, which encompasses K170 and three 
other basic residues (Fig. 3-8).   
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We found that deletion of the C-terminal region did not alter surface localization of 
DbpA, but abolished its ability to promote binding to 293 cells, dermatan sulfate and 
decorin (Fig. 3-9, “C11”).  A fortuitously generated mutant that resulted in the 
replacement of the C-terminal 11 residues with an unrelated 13-residue sequence also did 
not promote detectable binding to any of the DbpA substrates (Fig. 3-8, “C11+13”).  
These results are consistent with the previous implication of C-terminal lysines in decorin 
binding, and suggest that the C-terminal region is critical for the dermatan sulfate and 
293 cell binding by DbpA.   
Figure 3-7.  Amino acid 
sequence alignment of the 
decorin binding regions of 
the dbpA alleles used in 
this study.  Blue font 
indicates basic amino acids.  
Bolded lysine indicates 
critical residue for decorin 
binding in DbpA297. 
 
170 180 190 Figure 3-8.  Amino acid 
alignment of the C-
terminal regions of the 
dbpA alleles used in this 
study.   Blue font color 
indicates basic amino acid 
residues. 
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Figure 3-9.  The C-terminal region of DbpAVS461 is required for binding to 
mammalian cells and to purified GAGs.   
A) The C-terminal amino acid sequences of WT, truncated, and subsitituted 
DbpAVS461.  B) WT and mutant DbpAVS461are expressed on the surface of strain 
B314.  C) Radiolabeled B314 expressing the indicated forms of DbpAVS461 were 
added to wells with 293 epithelial cells, or D) dermatan sulfate, decorin, 
chondroitin-6-sulfate, or BSA.  The percent of bacteria bound was determined by 
scintillation count.  Each bar represents the mean of four independent 
determinations  SD with background binding subtracted. 
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Discussion 
 The bacterial factors that contribute to the ability of some Lyme disease 
spirochete strains to cause disseminated infection are not fully characterized, and may 
include surface proteins that mediate attachment to mammalian cells or ECM in target 
tissues.  The Lyme disease spirochete exhibits strain-specific variation in GAG-binding 
specificity that corresponds to variation in the mammalian cell types that are recognized 
in vitro (113).  B. burgdorferi encodes multiple GAG-binding proteins, including DbpA 
and B (57), Bgp (112), and BBK32 (56), and the in vitro expression pattern of at least 
some of these adhesins varies with strain (N. Parveen, personal communication).  In 
addition, B. burgdorferi might encode GAG-binding adhesins that exhibit strain variation 
in GAG recognition.  DbpA has long been known to be highly variable among Lyme 
disease spirochetes (123), and could contribute to such strain specific variation.   
After confirming that different recombinant DbpA alleles possessed GAG-
binding activity, we utilized an ospC promoter-based vector to express different DbpA 
alleles on the surface of the high passage, noninfectious strain B. burgdorferi B314, 
which lacks the dbpA-encoding Lp54, as well as any other linear plasmid (compare Fig. 
3-10, top panel versus bottom panel).   
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Given that strain B314 is not known to adhere to any cell line, ectopic expression of 
surface proteins in this strain provides means to analyze the binding properties of an 
adhesin in the absence of confounding alternate binding pathways. The set of the DbpA 
alleles analyzed included representatives of each of the three major species of Lyme 
Figure 3-10.  Plasmid profile of B. burgdorferi strain B314.  The non-infectious and 
nonadherent strain B314 was subjected to PCR using primer pairs that amplify segments of 
each endogenous plasmid, as described previously (120).  As a control to test for the ability of 
each primer pair to detect the corresponding endogenous plasmid, the infectious strain B31-
ML23, which contains all of the endogenous plasmids was analyzed in parallel (plasmids not 
present are a feature of this clone due to in vitro passage) (159).  Asterisk denotes that this 
band denotes that this faint band is not expected size (600bp).  M= 100bp ladder.  
B314 
B31-ML23 
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disease spirochete, as well as representatives of B. burgdorferi sensu stricto that  were 
associated with different abilities to disseminate in the mammalian host.  For each allele, 
ectopic expression resulted in the ability of the spirochete to bind to decorin, and to 
epithelial (but not endothelial or glial) cell monolayers, well above background levels. 
Each DbpA-expressing B314 derivative recognized purified dermatan sulfate, and in all 
cases, DbpA-mediated epithelial cell attachment was eliminated upon enzymatic removal 
of this class of GAGs.  Thus, a common property of diverse DbpA alleles is the ability to 
promote epithelial cell attachment through the recognition of dermatan sulfate GAGs.   
Although we detected this common binding activity for each DbpA allele, we 
also observed allelic differences in the level of adhesiveness. For example, DbpAPBr 
promoted greater than four-fold more efficient epithelial cell attachment than DbpAVS461, 
and more than 20-fold more efficient dermatan sulfate binding.   These differences were 
consistent from experiment to experiment and were a property of the allele expressed, 
because multiple clones of a given allele were associated with similar binding activities.   
The differences in binding could not be attributed to the levels of expression of different 
alleles.  First, no dramatic differences in expression levels were detected upon 
immunoblotting of outer membrane preparations with pooled antisera that collectively 
recognize the entire collection of DbpA alleles.  Second, to the degree that SDS-PAGE 
and Coomassie blue staining revealed minor potential differences in DbpA levels (Fig. 3-
11), we found no correlation between expression level and substrate binding.  
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For example, DbpAPBr and DbpAVS461, which as noted above differed dramatically in cell 
and GAG binding, were expressed at roughly equivalent levels.   
As predicted, highly homologous alleles displayed similar binding activities.  For 
example, the dermatan sulfate, decorin and 293 cell binding profiles of DbpAN40-D10/E9 
and DbpAB356, which are 99% identical in sequence, were virtually indistinguishable.  
Similarly, DbpA297 and DbpAB31, which are 90% identical, also mediated roughly 
equivalent levels of cell, decorin and dermatan sulfate binding. Consistent with the 
previously documented sequence diversity of DbpA alleles, we observed considerable 
intraspecies variation in adhesive activities: DbpA alleles derived from B. burgdorferi 
sensu stricto that varied considerably in sequence, e.g., DbpA297 and DbpAN40-D10/E9, also 
varied in attachment activities.  Interestingly, given that strain N40D10/E9 causes 
disseminated infection in mice (38), the observation that DbpAN40-D10/E9 promoted levels 
of adhesiveness lower than most other alleles indicates that robust DbpA-mediated in 
Figure 3-11.  Expression pattern of DbpA on the surface of B. burgdorferi strain 
B314.  15 g of total protein from the detergent phase of Triton X-114 extractions of B. 
burgdorferi strain B314 expressing the indicated DbpA allele were subjected to 15% 
SDS-PAGE and stained with Coomassie blue stain.  Arrows correspond to the DbpA 
protein expressed. 
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vitro adhesiveness is not a prerequisite for disseminated infection.  Related to this, 
DbpAN40-D10/E9 and DbpAB356 displayed similar binding activities in spite of the fact that 
B. burgdorferi N40D10/E9 and B356 differ considerably in their ability to disseminate in 
mice (38, 155).  
Decorin contains a chondroitin or dermatan sulfate GAG chain that is critical for 
recognition by DbpA (67), and for five of the six DbpA alleles analyzed here, we 
observed a strong correlation between decorin and dermatan sulfate binding. However, 
one allele, DbpAVS461, promoted relatively high level spirochetal attachment to decorin 
but low level binding to purified dermatan sulfate.  Therefore, although the dermatan 
sulfate GAG chain of decorin is critical for recognition by DbpA (67), dermatan sulfate 
and decorin binding are nonidentical.  Consistent with this observation, the protein core 
of decorin was previously shown to be required for detectable binding by DbpA in a 
radiometric assay (67).  Here we found that DbpAVS461 displayed a relatively poor 
activity in promoting 293 cell attachment, suggesting that at least in this instance, 
dermatan sulfate binding correlates with cell attachment more closely than decorin 
binding.  Definitive determination of the relative contribution of decorin and dermatan 
sulfate binding in cell attachment mediated by DbpA is complicated by the close 
structural relationship of these ligands, and awaits further study. 
Previous work showed that lysine residues K163 and K170 in the C-terminus of 
DbpA297, along with the centrally located lysine residue K82, were required for binding 
to decorin (26, 115).  The sequence of the DbpA C-terminus is highly divergent, and in 
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particular the DbpAVS461 C-terminus is quite dissimilar from that of DbpA297 (123).  
Nevertheless, the C-termini of all of the alleles tested are highly basic, and thus might 
contribute to GAG binding.  We found that the 11-residue C-terminal segment of VS461, 
which encompasses K170, is required for the ability of DbpAVS461 to promote spirochetal 
binding to cells, decorin and dermatan sulfate.  This and other relatively variable regions 
of DbpA might contribute to the allelic diversity of attachment activity.     
B. burgdorferi mutants that lack DbpA demonstrate a colonization defect in mice 
(137, 159).  In the current study, we showed that the adhesive activity of DbpA is subject 
to considerable allelic variation.  A detailed understanding of the molecular basis of this 
variation, combined with experimental infection by isogenic infectious strains that 
express different alleles of DbpA, may provide insight into the adhesive activities of this 
protein that contribute to infectivity and colonization in the mammalian host.    
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CHAPTER IV 
 
Discussion 
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 Host cell attachment is an important step for many pathogens in the establishment 
of infection and in their pathogenesis.  Borrelia species are the causative agents of a wide 
variety of diseases in mammals, including the human diseases Lyme disease and 
relapsing fever.  Borrelia burgdorferi sensu lato, the agents of Lyme disease, are capable 
of colonizing a variety of tissues including the tick midgut, the joints, heart, skin and 
neural tissue (142).  The differences in preferential tissue colonization between species of 
Lyme disease spirochetes have been well documented (53, 156, 163), and may contribute 
to the variable chronic symptoms seen in some Lyme disease patients.  In Europe and 
Asia, for example, Lyme disease is more commonly caused by B. afzelii and B. garinii.  
These species can cause chronic skin lesions and neurological complications respectively 
in untreated patients (141).  In contrast, B. burgdorferi is the predominant strain which 
causes Lyme disease in the United States and is associated with chronic arthritis in 
untreated patients.  The mechanism(s) of tissue tropism by Lyme disease spirochetes it is 
currently unknown.  Relapsing fever spirochetes such as B. hermsii are mainly found in 
the bloodstream of the infected host, and do not cause a chronic infection in healthy 
individuals.  The most common clinical findings in patients diagnosed with this disease 
are thrombocytopenia and anemia (22).  Relapsing fever Borreliae have been shown to 
bind to platelets and red blood cells (6, 68), although it is not understood how this 
interaction contributes to these symptoms. 
 In our study, we sought to examine the influence of the genetic background of the 
host on the outcome B. hermsii infection.  By daily monitoring of infected rag2-/- mice, 
we found that the innate immune response is under at least partial genetic control.  In 
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summary, we found that C57BL/6 rag2-/- mice were better able to control the infection 
than either Balb/C rag2-/- or C3H/HeN rag2-/- (Fig. 2-2, day 3) and male rag2-/- mice 
were more susceptible than females (Fig 2-4).  (For a more detailed discussion, see 
Chapter 2, pages 41-45).  A surprising result arose when infection of C57BL/6 rag2-/- 
mice was compared with its immunocompetent counterpart.  Of the immunocompetent 
mouse strains surveyed, the most sensitive strain was C57BL/6 at day 3 post infection 
(Fig 2-1).  In contrast, when rag2-/- mice in this background were examined, this group 
was the most resistant throughout the course of infection (compare Fig.2-1 and Fig. 2-2).  
The C57BL/6 mice used in our study were the Bailey substrain (C57BL/6 ByJ), which 
has a mutation in the interferon regulatory factor 3 (IRF3) gene, while the C57BL/6 rag2-
/- mice do not.  IRF3 is a transcription factor involved in toll-like receptor 4 (TLR4) 
signaling (61, 106), and one of three regulators of IFN that has been shown to be 
stimulated during viral infection (151).  The mutation in the irf3 gene in C57BL/6 ByJ 
mice was shown to lead to a defect in IFN which lead to increased sensitivity to 
Listeria monocytogenes infection (61).  Our results suggest that IRF3 may play a role in 
resistance to B. hermsii infection, and it would be interesting to compare infection in 
C57BL/6 and C57BL/6 ByJ mice in order to more thoroughly investigate this.  In 
addition, analysis of an IRF3/rag2 double knockout mouse would be useful in order to 
examine the role of IRF3 in B. hermsii infection in the absence of adaptive immunity.   
 This study was the first of its kind analyzing the role of strain background of the 
murine host in the outcome of relapsing fever.  Although we found that the innate 
immune response to B. hermsii infection is greatly influenced by the strain background, 
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and that an IFN response may be involved, we still do not know the specific innate 
immune mechanism(s) that are involved in resistance to this pathogen.  Analysis of blood 
chemistry panels of infected mice from different genetic backgrounds, as well as analysis 
of infection of IFN knockout mice would be useful in analyzing whether other cytokines 
are involved in response to relapsing fever infection.  In addition, Borrelia hermsii has 
been shown to evade complement killing by binding factor H, which inactivates the 
opsonin C3b (44, 132, 161).  The classical complement pathway requires an antibody 
response, and therefore would not be triggered in rag-/- mice.  The alternative 
complement pathway is activated independently of antibodies and involves the cleavage 
of C3 to C3b which is then coats the surface of invading pathogens (161).  C3-/- mice did 
not show any differences in the course of infection compared to wild-type mice (161), 
however, the role of C3 in the absence of an antibody response was not analyzed.  A 
simple assay to test whether genetic background may affect complement mediated killing 
of B. hermsii in the absence of antibody would be to perform serum killing assays using 
serum from rag2-/- mice of different genetic backgrounds.  Although it is possible that the 
ability to bind factor H may confer on B. hermsii uniform resistance to serum, one can 
speculate that some mice, such as C57BL/6 rag2-/-, might have higher levels of C3 that 
could promote killing.  An additional study would be to generate and analyze infection in 
C3/rag2 double knockout mice, which would be expected to be hypersensitive to 
relapsing fever infection in the absence of both complement- and antibody- mediated 
clearance of B. hermsii. 
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 The most striking findings from our study resulted from the histological analysis 
of tissue from infected mice which gave insight into the role of host cell attachment by B. 
hermsii in the clearance of this pathogen by macrophages.  B.hermsii causes 
thrombocytopenia and anemia in human patients as well as in mice (6, 62).  Although it 
has been shown that thrombocytopenic episodes coincide with peaks in bacteremia (5), 
the mechanisms that lead to the clearance of blood cells by B. hermsii during afebrile 
periods are not well understood.  In our study, we performed histological analyses of the 
liver and spleen in order to track the course of B. hermsii infection in rag2-/- mice.  The 
liver and spleen are known to play a role in the clearance of many pathogens, and Sambri 
et al. showed that the liver plays a role in the elimination of both B. hermsii and B. 
burgdorferi from the bloodstream (130).  In their study, the authors evaluated perfused 
rat livers for the ability to uptake and kill various radiolabeled Lyme and relapsing fever 
spirochetes.  When infused with radiolabeled bacteria, rat livers were able to rapidly 
uptake all Borrelia species examined, although the efficiency did vary between species 
(130).  Interestingly, no relapsing fever or Lyme disease spirochetes were recovered from 
the livers by culturing in BSK II medium indicating that the bacteria were killed by the 
liver.  In our study, we examined hematoxylin/eosin stained liver sections and saw 
evidence of extensive erythrophagocytosis by Kupffer cells (Fig. 2-5A).  Although B. 
hermsii cannot be identified by H&E stain, and thus it is not certain that the red-blood 
cells seen in Kupffer cells were bound to spirochetes, both B. hermsii and B. crocidurae, 
another relapsing fever spirochete, have been shown to bind RBC’s (30, 68) indicating it 
is indeed possible that the RBCs visualized within Kupffer cells were bound by B. 
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hermsii.  Using fluorescent in situ hybridization (FISH), spirochetes were found to be 
associated with RBCs in the liver, spleen and heart (Fig. 2-6).  In the liver samples, 
Kupffer cells could not be identified by FISH, and therefore we cannot be certain that the 
RBC’s associated with B. hermsii identified in this manner are located within these 
macrophages.  However, our data suggest that spirochete-associated RBCs may be 
cleared from the bloodstream of mice by uptake in Kupffer cells.  Sambri et al. could not 
recover B. burgdorferi by culture from infected Kupffer cells in their study suggesting 
that these macrophages in the liver are capable of uptake and killing of many Borrelia 
species (130).  Although the authors did not examine B. hermsii interaction with isolated 
Kupffer cells, these data suggest that the liver does indeed play a role in elimination of B. 
hermsii infections.   
 More recent studies have shown that Kupffer cells play a role in the immune 
response to B. burgdorferi and spirochetal infections.  Marangoni and colleagues 
demonstrated that in addition to B. garinii, L. interrogans and T. pallidum were able to 
induce TNF production in isolated rat Kupffer cells.  Interestingly, Polymyxin B which 
binds to LPS, reduced cytokine stimulation by L. interrogans by 50%, but had a 
negligible effect on B. garinii and T. pallidum both of which lack LPS.  These data 
indicate that a surface component specific to spirochetes may be responsible for 
activating cytokine production in  Kupffer cells (95).  Lee et al. observed direct 
interactions in vivo between B. burgdorferi and Kupffer cells in the liver vasculature via 
intravital microscopy.  Kupffer cells effectively trapped and phagocytosed spirochetes, 
which in turn activated iNKT cells leading to IFN production (83).  This study by Lee et 
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al. confirms the findings by Sambri et al. and demonstrates that Kupffer cells can in fact 
eliminate spirochetes from the bloodstream.  These data provide insight into mechanism 
of immune clearance of spirochetal pathogens.  However, to date no studies have 
provided evidence of a direct interaction between B. hermsii and Kupffer cells.  Our data 
suggest that such an interaction does indeed occur, and may be influenced by the genetic 
background of the mouse.  Although we did not see qualitative differences in the 
histopathology between tissues of rag2-/- mouse strains, C57BL/6 rag2-/- mice were able 
control bacteremia more effectively than either Balb/C rag2-/- and C3H rag2-/-.  Based on 
these data, it would be of interest to perform a similar study with Kupffer cells isolated 
from mice of different backgrounds.  A study of this kind could provide insight into 
mechanisms of clearance of B. hermsii infection and whether attachment to RBC’s plays 
a role in the clearance of this pathogen.  In sharp contrast to relapsing fever spirochetes, 
cell adhesion appears to play a very different role in Lyme disease pathogenesis in which 
spirochetes appear to use cell adhesion to establish and maintain infection.    
 Lyme disease is a multifaceted disease caused by spirochetes of the genus 
Borrelia.  In order to maintain enzoonotic its life cycle, Lyme disease Borreliae express 
numerous adhesins which allow colonization of the tick vector and subsequent 
colonization of mammalian host (89, 108, 168).  In order to establish and maintain 
infection, Lyme disease spirochetes maintain tight regulation of their surface adhesins, 
each which bind one or more cellular or extracellular matrix component (69, 76, 107, 
121).  Different Lyme disease genospecies have been shown to preferentially colonize 
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different tissues in the mammalian host.   However, it is not know these adhesin(s) 
contribute to the tissue tropism seem among various Lyme disease Borreliae. 
 Some strains of Lyme disease spirochete have the capacity to disseminate from 
the initial site of infection via the bloodstream and colonize other tissues, including skin, 
heart, joint, and nervous tissue.  In addition, Lyme disease Borreliae have been shown to 
bind to multiple different cell types in vitro.  These spirochetes express a plethora of 
adhesins, for which some the corresponding ligand(s) have been identified.  The 
multitude of adhesins may reflect the variety of tissue and cell types that Lyme disease 
Borreliae are known to bind to.  Consistent with this, DbpA promotes binding to 
epithelial cells, whereas the related adhesin DbpB promotes binding not only to epithelial 
but also to glial cells.  Additionally, different adhesins may play a role at different stages 
of extravasation.  A study by Norman et al. demonstrated that dissemination of B. 
burgdorferi through the vasculature of infected mice involved different stages which the 
authors termed tethering, dragging, stationary adhesion and extravasation.  This is 
reminiscent of leukocyte extravasation from the vasculature, which occurs in multiple 
steps, each mediated by different molecules (110, 126).  For example, the cell adhesion 
molecules L- and P-selectin mediates rolling adhesion, while stationary adhesion is 
mediated by 2-integrins (31, 88).  For B. burgdorferi, it was shown that BBK32 
mediated GAG and fibronectin binding were required for the various spirochete 
interactions with the vasculature (99, 104).  One can speculate then that multiple adhesins 
are required for invasion and colonization of tissues such as the heart.  As with adherence 
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to and escape from the vasculature, colonization may also involve multiple steps such 
each of which could require a different adhesin to recognize different host receptors.   
 In this study, we expressed alleles of the highly heterogeneous surface lipoprotein 
DbpA from six Lyme disease spirochetes on the surface of the non-adherent, non-
infectious B. burgdorferi strain B314.  B. burgdorferi, B. garinii, and B. afzelii are each 
associated with different chronic Lyme disease manifestations in humans (82, 150), and 
the collection used in this study included representatives from each of the three species 
(Table 3-3).  In summary, we found that all dbpA alleles tested conferred varying ability 
to bind epithelial cells, decorin, and dermatan sulfate to strain B314 (see chapter 3, pages 
76-81 for a detailed discussion on these results).  Based on our data, we made three 
important observations.  The first observation was that DbpAPBr appears to be in a class 
alone, showing the strongest binding phenotype to all binding to all substrates tested.  
DbpAPBr is, however, the only B. garinii allele tested in this study.  Analysis of DbpA 
alleles from additional strains of B. garinii for similar in vitro binding phenotypes may 
provide insight as to whether strong binding to decorin and/or dermatan sulfate is 
required to cause the neurological symptoms associated with this species.  Second, DbpA 
from B. afzelii strain VS461 bound to decorin more strongly (Fig. 3-5, left panel) than to 
dermatan sulfate (Fig. 3-5, right panel) or epithelial cells (Fig. 3-4).  The decorin binding 
domain of DbpA has been identified (115).  While it is currently unknown whether a 
specific domain of DbpA mediates GAG binding, these observations lead us to speculate 
that the two binding activities of DbpA may be separable.  However, we only tested the 
DbpA allele from one B. afzelii strain and it would be of interest to additional alleles 
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other B. afzelii strains which may provide insight in identifying the GAG binding domain 
of DbpA.  Third, the alleles DbpAN40 and DbpAB356 which share 99% homology have 
identical in vitro binding phenotypes.  It is interesting to note that while DbpAN40 does 
not bind to epithelial cells, decorin or dermatan sulfate at very high levels, B. burgdorferi 
strain N40 is very invasive in the mouse model (84), leading us to hypothesize that robust 
DbpA mediated binding may not be required for invasive disease.  In contrast, strain 
B356 does not cause invasive disease (155) which indicates that the in vitro binding 
phenotypes seen in our assay may not reflect disease phenotype in vivo.  The possibility 
exists that some DbpA alleles may recognize an as yet unidentified cell surface or ECM 
molecule which could contribute to the variation in binding levels by the different DbpA 
alleles used in this study.  This phenomenon could be explored in a future study by 
including a greater number of different cell types which express different GAG types and 
ECM molecules in our binding assays.  To our knowledge, there are no studies to date 
which evaluate how genetic variation of a specific Borrelial lipoprotein contributes to 
Lyme disease pathogenesis.  However, were able to show a specific interaction between 
all DbpA alleles examined with the GAG dermatan sulfate (Tables 3-4 and 3-5).  Our 
assays provided a starting point to evaluate the differences in the binding capabilities of 
DbpA alleles from different Lyme disease genospecies.  However, given the disparity 
noted between the in vitro binding properties of DbpAN40 and DbpAB356 and the invasive 
properties of their associated B. burgdorferi strains, we will use a method to evaluate how 
different DbpA alleles may contribute to disease in vivo. 
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  B. burgdorferi strain B314 is noninfectious and possesses only four circular 
plasmids and no linear plasmids (Fig. 3-10), thus, the strains generated for this study 
cannot be used in a traditional mouse infection model.  Thus, in order to evaluate the in 
vivo contribution of different DbpA  alleles in the pathogenesis of Lyme disease, we will 
complement a dbpBA null strain generated in the laboratory of Dr. Jon Skare (159).  The 
strain generated by Dr. Skare’s lab lacks lp25 which contains the pncA gene, which is 
required for mammalian infection by B. burgdorferi (119).  We will therefore use a 
shuttle vector containing pncA to express each dbpA gene (119).  In the current study, we 
used a shuttle vector containing the ospC promoter which drives very high level 
expression of DbpA.  For this future study, because we are evaluating DbpA in an 
infectious strain, we will use the native dbpA promoter to express each allele in order to 
achieve wild-type like expression levels.  In their study, Weening et al. showed that their 
dbpBA null was not infectious and that complementation restored infectivity to near wild-
type levels (159).  In our study, because we are complementing with dbpA alone, the ID50 
of our complemented strains are expected to be higher than that of the complemented 
strain used by Weening/Skare (~300 spirochetes) which was complemented with both 
DbpA and B.  We will therefore use an infectious dose of 104 Borrelia per infection.  
Although this dose is much higher than the ID50 of the parent strain (~150), it is lower 
than that of the null strain (>106) and also lower than the dose used by Shi et al. (105) 
where no difference in infectivity was seen between their dbpBA null strain and its parent 
(138).  As with strain B314, we expect that different dbpA alleles will have varying 
abilities to complement the dbpBA null strain which will be evaluated by extracting DNA 
94 
 
from various tissues from infected mice and measuring spirochetal load by quantitative 
real-time PCR.  One caveat to the design of this experiment is that the complemented 
strain is derived from a wild-type infectious strain, and as such we are evaluating the in 
vivo properties of DbpA in the presence of other adhesins.  For example, B. burgdorferi 
strain B356 and B. afzelii strain VS461 have been shown to cause a localized skin 
infection (141, 155).  We therefore expect that the dbpBA null strain complemented with 
DbpA from either of these strain to localize to the skin of an infected mouse.  However, 
B. burgdorferi expresses multiple adhesins on its surface including Bgp (112)  and 
BBK32 (118) which also bind to GAGs and may have redundant functions which could 
possibly lead to a lack of differences between the DbpA alleles we are analyzing. 
 In order circumvent the problem of evaluating the in vivo properties of different 
DbpA alleles in the presence of other adhesins, it is possible to use the strains generated 
in this study in a murine infection model using a high dose (~109) infection.  Although 
B314 is non-infectious, it possible to use a high dose, short duration infection and 
measure spirochetal DNA in tissue.  Additionally several studies have used intravital 
microscopy to evaluate borrelial interactions with murine vasculature in various tissues 
(83, 104) which could be used to evaluate strain B314 expressing different DbpA alleles.   
 In summary, we analyzed the role of host-cell interactions in the pathogensis of 
pathogenic Borreliae, Borrelia burgdorferi sensu lato and Borrelia hermsii.  In the case 
of the former, evidence in our study suggests that attachment to host cells is a critical step 
in the establishment of Lyme disease, is required for tissue colonization which can lead to 
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a plethora of chronic symptoms if left untreated.  In contrast, in the case of infection by 
B. hermsii we found evidence which suggests that attachment to red blood cells may lead 
to clearance of this pathogen from the bloodstream via phagocytosis in the liver.  Our 
studies provide a starting point for further research in these areas.     
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